<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Obes Rev</journal-id>
<journal-id journal-id-type="iso-abbrev">Obes Rev</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1467-789X</journal-id>
<journal-id journal-id-type="publisher-id">OBR</journal-id>
<journal-title-group>
<journal-title>Obesity Reviews</journal-title>
</journal-title-group>
<issn pub-type="ppub">1467-7881</issn>
<issn pub-type="epub">1467-789X</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30821060</article-id>
<article-id pub-id-type="pmc">6850662</article-id>
<article-id pub-id-type="doi">10.1111/obr.12836</article-id>
<article-id pub-id-type="publisher-id">OBR12836</article-id>
<article-id pub-id-type="other">OBR-10-18-3643.R2</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Etiology and Pathophysiology</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Etiology and Pathophysiology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A comprehensive diagnostic approach to detect underlying causes of obesity in adults</article-title>
<alt-title alt-title-type="left-running-head">van der Valk et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="obr12836-cr-0001">
<name>
<surname>van der Valk</surname>
<given-names>Eline S.</given-names>
</name>
<xref ref-type="aff" rid="obr12836-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="obr12836-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="obr12836-cr-0002">
<name>
<surname>van den Akker</surname>
<given-names>Erica L.T.</given-names>
</name>
<xref ref-type="aff" rid="obr12836-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="obr12836-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="obr12836-cr-0003">
<name>
<surname>Savas</surname>
<given-names>Mesut</given-names>
</name>
<xref ref-type="aff" rid="obr12836-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="obr12836-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="obr12836-cr-0004">
<name>
<surname>Kleinendorst</surname>
<given-names>Lotte</given-names>
</name>
<xref ref-type="aff" rid="obr12836-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="obr12836-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="obr12836-cr-0005">
<name>
<surname>Visser</surname>
<given-names>Jenny A.</given-names>
</name>
<xref ref-type="aff" rid="obr12836-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="obr12836-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="obr12836-cr-0006">
<name>
<surname>Van Haelst</surname>
<given-names>Mieke M.</given-names>
</name>
<xref ref-type="aff" rid="obr12836-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="obr12836-cr-0007">
<name>
<surname>Sharma</surname>
<given-names>Arya M.</given-names>
</name>
<xref ref-type="aff" rid="obr12836-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="obr12836-cr-0008">
<name>
<surname>van Rossum</surname>
<given-names>Elisabeth F.C.</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-0120-4913</contrib-id>
<xref ref-type="aff" rid="obr12836-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="obr12836-aff-0002">
<sup>2</sup>
</xref>
<address>
<email>e.vanrossum@erasmusmc.nl</email>
</address>
</contrib>
</contrib-group>
<aff id="obr12836-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Obesity Center CGG, Erasmus MC</named-content>
<institution>University Medical Center Rotterdam</institution>
<city>Rotterdam</city>
<country country="NL">The Netherlands</country>
</aff>
<aff id="obr12836-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Internal Medicine, Division of Endocrinology, Erasmus MC</named-content>
<institution>University Medical Center Rotterdam</institution>
<city>Rotterdam</city>
<country country="NL">The Netherlands</country>
</aff>
<aff id="obr12836-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Pediatrics, Erasmus MC</named-content>
<institution>University Medical Center Rotterdam</institution>
<city>Rotterdam</city>
<country country="NL">The Netherlands</country>
</aff>
<aff id="obr12836-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Clinical Genetics</named-content>
<institution>Amsterdam UMC</institution>
<city>Amsterdam</city>
<country country="NL">The Netherlands</country>
</aff>
<aff id="obr12836-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<institution>University of Alberta</institution>
<city>Edmonton</city>
<country country="CA">Canada</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
EFC van Rossum, Internist‐endocrinologist/Professor of Medicine, Head of Obesity Center CGG (Centrum Gezond Gewicht), Erasmus MC, University Medical Center Rotterdam, Room D‐428, PO Box 2040, 3000 CA Rotterdam, The Netherlands.<break></break>
Email: <email>e.vanrossum@erasmusmc.nl</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2019</year>
</pub-date>
<volume>20</volume>
<issue>6</issue>
<issue-id pub-id-type="doi">10.1111/obr.v20.6</issue-id>
<fpage>795</fpage>
<lpage>804</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>04</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>1</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2019 World Obesity Federation <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors. <italic>Obesity Reviews</italic> published by John Wiley &amp; Sons Ltd on behalf of World Obesity Federation</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:OBR-20-795.pdf"></self-uri>
<abstract>
<title>Summary</title>
<p>Obesity is a worldwide growing problem. When confronted with obesity, many health care providers focus on direct treatment of the consequences of adiposity. We plead for adequate diagnostics first, followed by an individualized treatment. We provide experience‐based and evidence‐based practical recommendations (illustrated by clinical examples), to detect potential underlying diseases and contributing factors. Adult patients consulting a doctor for weight gain or obesity should first be clinically assessed for underlying diseases, such as monogenetic or syndromic obesity, hypothyroidism, (cyclic) Cushing syndrome, polycystic ovarian syndrome (PCOS), hypogonadism, growth hormone deficiency, and hypothalamic obesity. The most important alarm symptoms for genetic obesity are early onset obesity, dysmorphic features/congenital malformations with or without intellectual deficit, behavioral problems, hyperphagia, and/or striking family history. Importantly, also common contributing factors to weight gain should be investigated, including medication (mainly psychiatric drugs, (local) corticosteroids, insulin, and specific β‐adrenergic receptor blockers), sleeping habits and quality, crash diets and yoyo‐effect, smoking cessation, and alcoholism. Other associated conditions include mental factors such as chronic stress or binge‐eating disorder and depression.Identifying and optimizing the underlying diseases, contributing factors, and other associated conditions may not only result in more effective and personalized treatment but could also reduce the social stigma for patients with obesity.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="obr12836-kwd-0001">Diagnostics</kwd>
<kwd id="obr12836-kwd-0002">genetic obesity</kwd>
<kwd id="obr12836-kwd-0003">hormones</kwd>
<kwd id="obr12836-kwd-0004">medication</kwd>
<kwd id="obr12836-kwd-0005">secondary causes</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-0001">
<funding-source>
<institution-wrap>
<institution>Elisabeth Foundation </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100001297</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="funding-0002">
<funding-source>Netherlands Organization of Scientific Research NWO</funding-source>
<award-id>91716453</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="3"></table-count>
<page-count count="10"></page-count>
<word-count count="3874"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.1 mode:remove_FC converted:12.11.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="obr12836-cit-0001" publication-type="journal">
<string-name>
<surname>van der Valk</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>van den Akker</surname>
<given-names>ELT</given-names>
</string-name>, <string-name>
<surname>Savas</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>A comprehensive diagnostic approach to detect underlying causes of obesity in adults</article-title>. <source xml:lang="en"/>Obesity Reviews. <year>2019</year>;<volume>20</volume>:<fpage>795</fpage>–<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1111/obr.12836</pub-id>
<pub-id pub-id-type="pmid">30821060</pub-id></mixed-citation>
</p>
</notes>
</front>
<body id="obr12836-body-0001">
<sec id="obr12836-sec-0001">
<label>1</label>
<title>INTRODUCTION</title>
<p>Obesity (body mass index [BMI] ≥30.0 kg/m<sup>2</sup>) is a chronic disease<xref ref-type="ref" rid="obr12836-bib-0001">1</xref> that is a worldwide growing problem.<xref ref-type="ref" rid="obr12836-bib-0002">2</xref> In 2015, over 603 million adults had obesity, and 4.0 million deaths were yearly accountable to a high BMI.<xref ref-type="ref" rid="obr12836-bib-0003">3</xref> When facing a patient with obesity, most clinicians focus on treating the associated comorbidities and/or simply recommend weight loss. The diagnostic phase, which is typically used when assessing other clinical problems, is often overlooked in obesity. Whereas in other clinical problems, such as hypertension, clinicians are alert to consider a wide variety of secondary causes.<xref ref-type="ref" rid="obr12836-bib-0004">4</xref> For obesity, a diagnostic phase to detect underlying diseases or other factors that hinder weight loss is recommended by some<xref ref-type="ref" rid="obr12836-bib-0005">5</xref> but not all clinical practice guidelines. The European guideline recommends a diagnostic phase; however, specific examples of diseases or factors that may contribute to obesity are lacking.<xref ref-type="ref" rid="obr12836-bib-0005">5</xref> Others do not mention the necessity to identify underlying contributing factors.<xref ref-type="ref" rid="obr12836-bib-0006">6</xref>, <xref ref-type="ref" rid="obr12836-bib-0007">7</xref> This paper aims to help clinicians to deepen the diagnostic phase with a comprehensive overview of possible contributors to weight gain for an individual.</p>
<p>Currently, on a societal level, it is widely believed that obesity is simply the consequence of overconsuming unhealthy foods and lack of exercise. However, on an individual level, there are many other contributing factors or underlying diseases, which are often not identified and may prove significantly associated with weight gain and barriers to weight loss. We suggest that clinicians should first detect and address underlying diseases and contributing factors, before starting obesity treatment. Besides lifestyle‐related factors, other factors include hormonal and genetic abnormalities, mental and socio‐cultural factors, and side effects of medications. Identifying these underlying factors may lead to more personalized treatment strategies, can also increase patients' understanding of their obesity, and reduce their social stigma.</p>
<sec id="obr12836-sec-0002">
<label>1.1</label>
<title>Clinical presentation</title>
<sec id="obr12836-sec-0003">
<label>1.1.1</label>
<title>Clinical Case A</title>
<p>A 66‐year‐old man, known with type 2 diabetes mellitus and eczema, was referred because of obesity. Since the last decade, he became increasingly heavier, with a rapid weight gain of 30 kg in the last year. He noticed red striae under his armpits and suffered from mood swings and decreased libido. A detailed past medication list showed several episodes of using clobetason cream, triamcinolone, desoximetason, and one short course of prednisone in the last 8 years. Moreover, in the last year, he had used large amounts of mometason cream on his whole back and arms because of severe eczema. We saw a man weighing 168 kg (BMI 59.5 kg/m<sup>2</sup>) with pronounced abdominal obesity with purple striae, hematomas, and severe non‐pitting ankle edema. Laboratory results are shown in Table <xref ref-type="table" rid="obr12836-tbl-0001">1</xref>. We concluded that there was severe obesity, with multiple contributing causes: an exogenous Cushing syndrome due to the use of large amounts of dermal corticosteroids, late‐onset hypogonadism (which can be a consequence of obesity but also poses an opportunity for treatment<xref ref-type="ref" rid="obr12836-bib-0008">8</xref>), and non‐pitting lymphedema. The subclinical hypothyroidism was considered a consequence of obesity.<xref ref-type="ref" rid="obr12836-bib-0009">9</xref>, <xref ref-type="ref" rid="obr12836-bib-0010">10</xref> A multidisciplinary strategy comprised gradual tapering of topical corticosteroids and lymphedema compression therapy by his dermatologist, testosterone supplementation, and an exercise program. After 2 years, he had lost 35 kg, his clinical condition improved, and testosterone and TSH levels had normalized. This case shows the importance of a combined approach taking into account all factors that contribute to obesity and counteract weight loss.</p>
<table-wrap id="obr12836-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Laboratory results patient 1</p>
</caption>
<table frame="hsides" rules="groups">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Value</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Reference Value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TSH</td>
<td align="left" colspan="1" rowspan="1" valign="top">6.030 mU/L</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.4‐4.3 mU/L</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">FT4</td>
<td align="left" colspan="1" rowspan="1" valign="top">15.4 pmol/L</td>
<td align="left" colspan="1" rowspan="1" valign="top">11‐25 pmol/L</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Urinary cortisol first measurement</td>
<td align="left" colspan="1" rowspan="1" valign="top">39 nmol/24 h</td>
<td align="left" colspan="1" rowspan="2" valign="top">5‐133 nmol/24 h</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Urinary cortisol second measurement</td>
<td align="left" colspan="1" rowspan="1" valign="top">48 nmol/24 h</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Testosterone</td>
<td align="left" colspan="1" rowspan="1" valign="top">5.05 nmol/L</td>
<td align="left" colspan="1" rowspan="1" valign="top">10‐30 nmol/L</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SHBG</td>
<td align="left" colspan="1" rowspan="1" valign="top">40 nmol/L</td>
<td align="left" colspan="1" rowspan="1" valign="top">10‐70 nmol/L</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Calculated free testosterone</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.0839 nmol/L</td>
<td align="left" colspan="1" rowspan="1" valign="top">&gt;220 pmol/L<xref ref-type="fn" rid="obr12836-note-0001">a</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot id="obr12836-ntgp-0001">
<fn id="obr12836-note-0001">
<label>a</label>
<p>In the presence of symptoms.<xref ref-type="ref" rid="obr12836-bib-0093">93</xref>
</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="obr12836-sec-0004">
<label>1.1.2</label>
<title>Clinical Case B</title>
<p>A 48‐year‐old woman was referred because of severe obesity with type 2 diabetes, with no long‐term effect of previous diets. Her overweight started around her first year of life, and later she had been treated in a mental health institute for her eating behavior. Since she was a baby, she always had an increased appetite. Several family members, mostly from her mother's side, had obesity. Interestingly, she reported that even during the Dutch extreme famine of 1945, her maternal grandfather had obesity. We saw a woman with red hair, weighing 117 kg (BMI 41.5 kg/m<sup>2</sup>). No other physical abnormalities were found.</p>
<p>We suspected a monogenetic cause of her obesity, because of the young age of onset, hyperphagia, red hair, and family history. Diagnostic screening of 52 obesity associated genes revealed two mutations in the melanocortin 4 receptor gene <italic>(MC4R)</italic> gene, of whom one is known to be pathogenic (c.[105C &gt; A], p.[Tyr35*]), whereas the other is a variant of unknown significance (VUS). Her daughter, who had obesity since the age of three, had inherited both <italic>MC4R</italic> mutations. Her father, who developed obesity at an older age, had no <italic>MC4R</italic> mutations.</p>
<p>In patients with pathogenic <italic>MC4R</italic> mutations long‐term weight maintenance is difficult to achieve.<xref ref-type="ref" rid="obr12836-bib-0011">11</xref> The response to bariatric surgery seems to be positive; however, long‐term results are still being investigated.<xref ref-type="ref" rid="obr12836-bib-0012">12</xref> Additionally, new pharmacological treatment options are arising that target MC4R.<xref ref-type="ref" rid="obr12836-bib-0013">13</xref> Recently, effective pharmacological treatment for another type of monogenetic obesity, caused by pathogenic <italic>POMC</italic> gene mutations, has become available.<xref ref-type="ref" rid="obr12836-bib-0014">14</xref> It is therefore relevant to identify underlying monogenic causes of obesity, which also may reduce the patient's obesity stigma.</p>
</sec>
</sec>
</sec>
<sec id="obr12836-sec-0005">
<label>2</label>
<title>METHODS</title>
<p>Due to the comprehensive nature of the subject, we selected subtopics based on clinical experience. For each subtopic, we searched databases such as the Cochrane library (February 2018) and MEDLINE library for relevant articles. We preferably selected publications of the last 5 years. Older publications were included if commonly referenced, highly regarded, or relevant to the topic. Reference lists of relevant identified articles were also searched.</p>
</sec>
<sec id="obr12836-sec-0006">
<label>3</label>
<title>ASSESSMENT OF OBESITY—CLINICAL HISTORY</title>
<p>Weight gain occurs when the energy homeostasis is chronically “out of balance.” This occurs either due to changes in total energy intake or in total energy expenditure, the latter being the sum of a person's resting energy expenditure plus a person's thermogenesis during activities.<xref ref-type="ref" rid="obr12836-bib-0015">15</xref> A clinical consult addressing obesity should therefore focus on what causes this excess and what maintains it. Examples to guide the clinical approach of identifying underlying causes and contributing factors, roughly grouped in lifestyle‐related factors, medication, (neuro‐)endocrine factors, genetic factors, and mental factors, are shown in Figure <xref ref-type="fig" rid="obr12836-fig-0001">1</xref>.</p>
<fig fig-type="Figure" id="obr12836-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Recognizing underlying causes of obesity in adults<italic>. ADD, attention deficit disorder; PCOS, polycystic ovarian syndrome; MC4R, melanocortin 4 receptor; POMC, proopiomelanocortin; PPI, proton pump inhibitors; OC, oral contraceptives; OSA, obstructive sleep apnea; OSFED, other specified feeding and eating disorders</italic> [Colour figure can be viewed at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">http://wileyonlinelibrary.com</ext-link>]</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="OBR-20-795-g001"></graphic>
</fig>
<sec id="obr12836-sec-0007">
<label>3.1</label>
<title>Lifestyle‐related factors involved in weight gain</title>
<p>Globally, the obesity pandemic is largely the consequence of increased energy consumption.<xref ref-type="ref" rid="obr12836-bib-0016">16</xref> However, in individual patients, there may be several reasons why a person has an increased caloric intake or decreased energy expenditure, which may even be modifiable. Often, there is a complex interplay of multiple social, psychological, and biological factors altogether resulting in excess energy intake.</p>
<p>For example, in some cultures, exorbitant amounts of food are associated with hospitality. Also, some patients may be unable to prioritize weight management in light of financial problems, relationship issues, or other circumstances requesting their attention. On an individual level, patients may overeat because they experience increased hunger or appetite. For example, this occurs in patients who have been on very low calorie‐diets without exercise or behavioral therapy, often referred to as the “yo‐yo‐effect.” The weight regain that follows may be associated with altered “hunger hormones” (eg, ghrelin) and satiety hormones' (eg, leptin and peptide YY [PYY]) that can remain altered even a year after ending the diet.<xref ref-type="ref" rid="obr12836-bib-0017">17</xref> Some individuals may overeat as a coping strategy for other, psychological factors such as emotions.<xref ref-type="ref" rid="obr12836-bib-0018">18</xref>Next, a decreased quantity or quality of sleep can induce weight gain.<xref ref-type="ref" rid="obr12836-bib-0019">19</xref> This may lead to a desire for high caloric food,<xref ref-type="ref" rid="obr12836-bib-0020">20</xref> imbalance of appetite hormones (eg, ghrelin and leptin),<xref ref-type="ref" rid="obr12836-bib-0021">21</xref> as well as increased hypothalamic–pituitary–adrenal‐axis reactivity<xref ref-type="ref" rid="obr12836-bib-0022">22</xref> yielding higher cortisol levels which may also enhance obesity.<xref ref-type="ref" rid="obr12836-bib-0023">23</xref>, <xref ref-type="ref" rid="obr12836-bib-0024">24</xref> Circadian misalignment, such as in shift work, is associated with a decreased daily energy expenditure and increased caloric intake.<xref ref-type="ref" rid="obr12836-bib-0025">25</xref>
<sup>,</sup>
<xref ref-type="ref" rid="obr12836-bib-0026">26</xref> As for sleep quality, obstructive sleep apnea (OSA) is especially notable as it seems to have a bidirectional relation with obesity. OSA occurs more frequently in obesity, but the sleep disturbances belonging to it may again promote weight gain enhancing behavioral, metabolic, and/or hormonal.<xref ref-type="ref" rid="obr12836-bib-0027">27</xref> It is not fully clear whether OSA treatment has an effect on body weight.<xref ref-type="ref" rid="obr12836-bib-0028">28</xref>, <xref ref-type="ref" rid="obr12836-bib-0029">29</xref>, <xref ref-type="ref" rid="obr12836-bib-0030">30</xref>
</p>
<p>When there is no notable change in energy intake, the problem may be altered energy expenditure, which can be either the result of decreased activity or decreased resting metabolism.</p>
<p>Recently, several possible influencers of resting metabolism have been identified. For example, weight loss itself can already affect the total energy expenditure, as this decreases more than is expected from the change in body composition only. This may be due to adaptive thermogenesis, that may hinder further weight loss.<xref ref-type="ref" rid="obr12836-bib-0031">31</xref> Also, an important contributor to a decreased metabolism is a sedentary lifestyle.<xref ref-type="ref" rid="obr12836-bib-0032">32</xref> Interesting associations have been found for options to interrupt the continuous sitting, eg, by intermittent standing, moving, or fidgeting, also called nonexercise activity thermogenesis (NEAT).<xref ref-type="ref" rid="obr12836-bib-0033">33</xref> Another possible determinant and future target regarding resting energy expenditure is the activity of brown adipose tissue (BAT).<xref ref-type="ref" rid="obr12836-bib-0034">34</xref> BAT, which was found to be also present in adult humans and basically burns calories into heat, can be stimulated by physical activity or cold exposure. This has been shown to result in a significant decrease in fat mass, with maintenance of lean mass.<xref ref-type="ref" rid="obr12836-bib-0035">35</xref> Nicotine can also stimulate BAT,<xref ref-type="ref" rid="obr12836-bib-0036">36</xref> possibly explaining the subtle weight gain that patients who quit smoking experience (together with increased appetite and psychological factors). Importantly, this modest weight gain does usually not outweigh the beneficial effects of smoking cessation. Education and guidance may limit the weight gain when patients quit smoking.<xref ref-type="ref" rid="obr12836-bib-0037">37</xref>
</p>
</sec>
<sec id="obr12836-sec-0008">
<label>3.2</label>
<title>Medication</title>
<p>Medication can affect the energy homeostasis mainly by promoting hunger or by decreasing resting metabolism. In our clinical experience, we find it helpful to taper or stop medication with weight gaining effects<xref ref-type="ref" rid="obr12836-bib-0038">38</xref> prior to a weight‐reducing intervention, as this may enhance the weight reduction. An overview of medication that may induce weight gain is provided in Table <xref ref-type="table" rid="obr12836-tbl-0002">2</xref>.</p>
<table-wrap id="obr12836-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Drugs that may induce weight gain</p>
</caption>
<table frame="hsides" rules="groups">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="char" char="." span="1"/>
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="bottom">Drug Class</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Examples of Specific Agents</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Estimated Weight Gaining‐Effect per Agent</th>
<th align="char" colspan="1" rowspan="1" valign="bottom">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="4" valign="top">Antidepressants</td>
<td align="left" colspan="1" rowspan="1" valign="top">Citalopram</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>26% higher chance of an episode of 5% weight gain</p>
<p>Mean weight gain during &gt;4 months of treatment 1.69 kg</p>
</td>
<td align="char" colspan="1" rowspan="4" valign="top">
<xref ref-type="ref" rid="obr12836-bib-0038">38</xref>, <xref ref-type="ref" rid="obr12836-bib-0039">39</xref>, <xref ref-type="ref" rid="obr12836-bib-0094">94</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mirtazapine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>50% higher chance of an episode of 5% weight gain</p>
<p>Mean weight gain 2.59 kg during &gt;4 months treatment</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Amitryptilline</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>17% higher chance of an episode of 5% weight gain</p>
<p>Mean weight gain 2.24 kg durine &gt;4 months treatment</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Paroxetine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Mean weight gain after &gt;4 months of treatment 2.73 kg</p>
<p>5% higher chance of an episode of 5% weight gain</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="6" valign="top">Antipsychotics</td>
<td align="left" colspan="1" rowspan="1" valign="top">Olanzapine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>3.8 kg to 16.2 kg in youth</p>
<p>29% increases ≥7% in body weight</p>
</td>
<td align="char" colspan="1" rowspan="6" valign="top">
<xref ref-type="ref" rid="obr12836-bib-0038">38</xref>, <xref ref-type="ref" rid="obr12836-bib-0040">40</xref>, <xref ref-type="ref" rid="obr12836-bib-0095">95</xref>, <xref ref-type="ref" rid="obr12836-bib-0096">96</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lithium</td>
<td align="left" colspan="1" rowspan="1" valign="top">4‐12 kg weight increase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Clozapine</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.9‐9.5 kg in youth</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Quetiapine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>2.3‐6.1 kg in youth</p>
<p>25% increases ≥7% in body weight</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Risperidon</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>1.9‐7.2 kg in youth</p>
<p>18% increases ≥7% in body weight</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ziprasidone</td>
<td align="left" colspan="1" rowspan="1" valign="top">9.8% increases ≥7% in body weight</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3" valign="top">Anti‐epileptics</td>
<td align="left" colspan="1" rowspan="1" valign="top">Carbamazepine</td>
<td align="left" colspan="1" rowspan="1" valign="top">7‐15 kg weight gain</td>
<td align="char" colspan="1" rowspan="3" valign="top">
<xref ref-type="ref" rid="obr12836-bib-0038">38</xref>, <xref ref-type="ref" rid="obr12836-bib-0096">96</xref>, <xref ref-type="ref" rid="obr12836-bib-0097">97</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gabapentin</td>
<td align="left" colspan="1" rowspan="1" valign="top">57% gains ≥5% of baseline weight</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Valproic acid</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>47% gains &gt;10% of baseline weight, 24% gains 5‐10% weight</p>
<p>0.5‐6 kg weight gain on average</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">Anti‐diabetics</td>
<td align="left" colspan="1" rowspan="1" valign="top">Insulin</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.78‐6 kg weight gain in the first year</td>
<td align="char" colspan="1" rowspan="2" valign="top">
<xref ref-type="ref" rid="obr12836-bib-0096">96</xref>, <xref ref-type="ref" rid="obr12836-bib-0098">98</xref>, <xref ref-type="ref" rid="obr12836-bib-0099">99</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SU derivates</td>
<td align="left" colspan="1" rowspan="1" valign="top">2‐4 kg over 1 year of treatment</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">Anti‐hypertensives</td>
<td align="left" colspan="1" rowspan="1" valign="top">α‐Adrenergic blockers</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.4‐2.0 kg</td>
<td align="char" colspan="1" rowspan="1" valign="top">
<xref ref-type="ref" rid="obr12836-bib-0100">100</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Β‐Adrenergic blockers</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.2‐kg mean weight difference when compared with other antihypertensives</td>
<td align="char" colspan="1" rowspan="1" valign="top">
<xref ref-type="ref" rid="obr12836-bib-0044">44</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">Corticosteroids</td>
<td align="left" colspan="1" rowspan="1" valign="top">Systemic corticosteroids</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Depending on doses, indication, and large individual variation</p>
<p>Rheumatoid arthritis: weight increase 4% to 8%</p>
<p>70% of patients report weight gain</p>
</td>
<td align="char" colspan="1" rowspan="1" valign="top">
<xref ref-type="ref" rid="obr12836-bib-0038">38</xref>, <xref ref-type="ref" rid="obr12836-bib-0101">101</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Local corticosteroids</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Unknown</p>
<p>association of higher BMI in women</p>
</td>
<td align="char" colspan="1" rowspan="1" valign="top">
<xref ref-type="ref" rid="obr12836-bib-0042">42</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3" valign="top">Others</td>
<td align="left" colspan="1" rowspan="1" valign="top">Proton pump inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">Possible association with weight gain</td>
<td align="char" colspan="1" rowspan="1" valign="top">
<xref ref-type="ref" rid="obr12836-bib-0050">50</xref>, <xref ref-type="ref" rid="obr12836-bib-0102">102</xref>, <xref ref-type="ref" rid="obr12836-bib-0103">103</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Protease inhibitors</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Lipodystrophy</p>
<p>Average weight gain 8kg in a study of 10 patients</p>
</td>
<td align="char" colspan="1" rowspan="1" valign="top">
<xref ref-type="ref" rid="obr12836-bib-0038">38</xref>, <xref ref-type="ref" rid="obr12836-bib-0104">104</xref>, <xref ref-type="ref" rid="obr12836-bib-0105">105</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Anti‐histamines</td>
<td align="left" colspan="1" rowspan="1" valign="top">Association with higher weight and waist circumference</td>
<td align="char" colspan="1" rowspan="1" valign="top">
<xref ref-type="ref" rid="obr12836-bib-0038">38</xref>, <xref ref-type="ref" rid="obr12836-bib-0047">47</xref>, <xref ref-type="ref" rid="obr12836-bib-0103">103</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Drugs that are frequently used in psychiatry, such as specific selective serotonin reuptake inhibitors or antipsychotic agents, are well‐known to promote weight gain. The strongest weight change is seen in amitriptyline, mirtazapine, and paroxetine.<xref ref-type="ref" rid="obr12836-bib-0039">39</xref> As for antipsychotic drugs, olanzapine and clozapine induce the highest weight gain.<xref ref-type="ref" rid="obr12836-bib-0040">40</xref> Also, several anti‐epileptic drugs should be noted. Although most prescribers are aware of these side effects, in patients with severe obesity, a medication switch to less obesogenic drugs should be considered if possible.<xref ref-type="ref" rid="obr12836-bib-0038">38</xref>
</p>
<p>It is well‐known that systemic corticosteroids can cause weight gain. For the treatment of rheumatoid arthritis, for example, it was found that low‐dose prednisone is associated with a weight increase of 4% to 8%.<xref ref-type="ref" rid="obr12836-bib-0041">41</xref> Corticosteroids can be administered in many forms. Often overlooked are the local forms, which we recently reported to be associated with increased BMI and waist circumference when compared with non‐corticosteroid users in a large population‐based cohort.<xref ref-type="ref" rid="obr12836-bib-0042">42</xref> Local corticosteroids may also have systemic effects resulting in weight gain, in a similar matter as local corticosteroids having other systemic effects, such as adrenal insufficiency,<xref ref-type="ref" rid="obr12836-bib-0043">43</xref> which needs further research. A weight gaining systemic effect of local corticosteroids is likely in patients using large quantities on a frequent basis, particularly if they show additional Cushingoid features, such as abdominal obesity, peripheral atrophy, plethora, and purple striae, as demonstrated by clinical case A.</p>
<p>The initiation of insulin therapy or sulphonylurea derivates in patients with type 2 diabetes can be accompanied by weight gain.<xref ref-type="ref" rid="obr12836-bib-0038">38</xref> Blood‐glucose lowering drugs without weight inducing effects, such as glucagon‐like peptide‐1 analogues, metformin, and sodium‐glucose cotransporter‐2 inhibitors,<xref ref-type="ref" rid="obr12836-bib-0038">38</xref> can be good alternatives if weight loss is desired.</p>
<p>Other drugs that have been shown to induce obesity are non‐selective β‐adrenergic receptor blockers.<xref ref-type="ref" rid="obr12836-bib-0038">38</xref>, <xref ref-type="ref" rid="obr12836-bib-0044">44</xref> If prescribed for hypertension, one could consider replacing them with other antihypertensive agents such as ACE‐inhibitors or angiotensin receptor blockers.<xref ref-type="ref" rid="obr12836-bib-0044">44</xref> The weight increase is more profound in metoprolol than in carvedilol. Interestingly, the weight increase was worse in subjects who already had severe obesity.<xref ref-type="ref" rid="obr12836-bib-0045">45</xref>
<sup>,</sup>
<xref ref-type="ref" rid="obr12836-bib-0046">46</xref> In HIV patients, the start of protease inhibitors has also been associated with weight gain and increased deposition of visceral adipose tissue.<xref ref-type="ref" rid="obr12836-bib-0038">38</xref> Another association has been found in users of H1 antihistamines, who were more likely to be overweight than non‐users.<xref ref-type="ref" rid="obr12836-bib-0047">47</xref>
</p>
<p>Regarding hormonal contraceptives, there is no large effect on weight, although available evidence is insufficient.<xref ref-type="ref" rid="obr12836-bib-0048">48</xref> However, we cannot rule out that some women experience excessive weight gain due to individual differences.</p>
<p>Also, for several other agents, such as proton pump inhibitors and alpha blockers, weight gaining effects have been reported.<xref ref-type="ref" rid="obr12836-bib-0049">49</xref>, <xref ref-type="ref" rid="obr12836-bib-0050">50</xref>
</p>
</sec>
<sec id="obr12836-sec-0009">
<label>3.3</label>
<title>Genetic causes of obesity</title>
<p>An overview of (mono)genetic obesity disorders is summarized in Table <xref ref-type="table" rid="obr12836-tbl-0003">3</xref>. The genetics of obesity are complex. In the general population, the fat‐mass and obesity associated gene (<italic>FTO</italic>) has shown the strongest association to obesity.<xref ref-type="ref" rid="obr12836-bib-0051">51</xref> Besides these polygenic associations that have not been fully elucidated as yet, only a small percentage of the patients with obesity can be classified as having a monogenic or syndromic obesity disorder.<xref ref-type="ref" rid="obr12836-bib-0052">52</xref>
</p>
<table-wrap id="obr12836-tbl-0003" orientation="portrait" position="float" xml:lang="en">
<label>Table 3</label>
<caption>
<p>Examples of relevant genetic obesity disorders</p>
</caption>
<table frame="hsides" rules="groups">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="bottom"></th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Syndrome</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Clinical Symptoms<xref ref-type="ref" rid="obr12836-bib-0055">55</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Dysmorphic Features</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Estimated Prevalence<xref ref-type="ref" rid="obr12836-bib-0106">106</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Reference</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="4" valign="top">Syndromic obesity with developmental delay</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prader‐Willi syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Developmental delay and intellectual disability,</p>
<p>(prenatal) hypotonia, feeding difficulties</p>
<p>Failure to thrive, hyperphagia, neurologic, and cognitive disturbances</p>
<p>Hypogonadism</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Almond‐shaped eyes, strabismus, thin upper lip, downturned corners of the mouth</p>
<p>Short stature</p>
<p>Genital hypoplasia</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>1/15.000‐1/30.000</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cassidy and Driscoll<xref ref-type="ref" rid="obr12836-bib-0107">107</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bardet‐Biedl syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Developmental delay</p>
<p>Intellectual disability</p>
<p>Retinal dystrophy</p>
<p>Renal dysfunction</p>
<p>Hypogonadism</p>
<p>Cardiac abnormalities</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Post‐axial polydactyly</p>
<p>Dental crowding</p>
<p>High‐arched palate</p>
<p>Hypodontia</p>
<p>Malocclusion</p>
<p>Enamel hypoplasia</p>
<p>Micropenis</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>1/160.000 (northern European)</p>
<p>1/13.500 (specific populations)</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Forsythe et al<xref ref-type="ref" rid="obr12836-bib-0108">108</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">16p11.2 deletion syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Developmental delay</p>
<p>Mild intellectual disability</p>
<p>Autism spectrum disorders</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Variable presentation</p>
<p>Macrocephaly</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3 in 10.000</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dell'edera et al<xref ref-type="ref" rid="obr12836-bib-0109">109</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Albright hereditary osteodystrophy</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Short stature,</p>
<p>subcutaneous ossifications</p>
<p>Maternally inherited <italic>GNAS</italic> mutations: Hormone resistance (eg, parathyroid hormone)sometimes developmental delay and intellectual disability</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Round facies Brachydactyly fourth/fifth metacarpals</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.79 in 100.000</td>
<td align="left" colspan="1" rowspan="1" valign="top">Haldeman‐Englert et al<xref ref-type="ref" rid="obr12836-bib-0058">58</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" valign="top">
<p>Genetic obesity without developmental delay</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">MC4R deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Hyperphagia</p>
<p>Accelerated linear growth</p>
<p>Disproportionate hyperinsulinemia</p>
<p>Low/normal blood pressure</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not apparent</td>
<td align="left" colspan="1" rowspan="1" valign="top">2%‐5% of subjects with extreme pediatric obesity</td>
<td align="left" colspan="1" rowspan="1" valign="top">Martinelli et al<xref ref-type="ref" rid="obr12836-bib-0110">110</xref>, <xref ref-type="ref" rid="obr12836-bib-0111">111</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Leptin (receptor) deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Extreme hyperphagia</p>
<p>Frequent infections</p>
<p>Hypogonadotropic hypogonadism</p>
<p>Mild hypothyroidism</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not apparent</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Leptin receptor deficiency: 2%‐3% in severely obese subjects</p>
<p>Leptin deficiency: Fewer than 100 patients worldwide</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Farooqi et al<xref ref-type="ref" rid="obr12836-bib-0112">112</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">POMC deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyperphagia, ACTH deficiency, pale skin, and red hair</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not apparent</td>
<td align="left" colspan="1" rowspan="1" valign="top">Unknown</td>
<td align="left" colspan="1" rowspan="1" valign="top">Krude et al<xref ref-type="ref" rid="obr12836-bib-0113">113</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PCSK1 deficiency</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<p>Adrenal, gonadotropic, somatotropic, and thyrotropic insufficiency</p>
<p>severe malabsorptive neonatal diarrhea</p>
<p>central diabetes insipidus</p>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not apparent</td>
<td align="left" colspan="1" rowspan="1" valign="top">Unknown</td>
<td align="left" colspan="1" rowspan="1" valign="top">RamosMolina et al<xref ref-type="ref" rid="obr12836-bib-0114">114</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Screening for these conditions is not routinely done in clinical practice. As new therapies are arising that target specific types of obesity, we here plead for screening for genetic obesity in a subgroup of patients who have a high clinical suspicion for these types of genetic obesity. A recent study found a confirmed diagnosis of genetic obesity in 3.9% of patients who were clinically suspected of genetic obesity.<xref ref-type="ref" rid="obr12836-bib-0053">53</xref> Indications for genetic screening include an early age of onset, below 5 years of age,<xref ref-type="ref" rid="obr12836-bib-0054">54</xref>, <xref ref-type="ref" rid="obr12836-bib-0055">55</xref> (or in adult populations a prepubertal onset), a family history with striking weight differences between family members (which may indicate monogenic obesity), and severe hyperphagia (which can be seen in monogenetic obesity‐with and without intellectual deficit). Furthermore, characteristics such as intellectual deficit or developmental delay, congenital malformations, visual impairment and/or deafness, and abnormal growth parameters (head circumference and height) may be indicative for syndromic obesity. Examples of syndromic obesity are Prader‐Willi syndrome (characterized by hypotonia and feeding problems in infancy, and later in life hyperphagia and obesity, short stature, intellectual deficit and hypogonadotropic hypogonadism<xref ref-type="ref" rid="obr12836-bib-0056">56</xref>), Bardet‐Biedl syndrome (intellectual deficit, retinal dystrophy or pigmentary retinopathy, polydactyly, hypogonadism, and nephropathy), and the 16p11.2 deletion syndrome (intellectual deficit, speech development problems, autism, macrocephaly, and epilepsy). There is a large variability of these symptoms among affected patients.<xref ref-type="ref" rid="obr12836-bib-0057">57</xref> Mild to moderate intellectual disability is also seen in patients with pseudohypoparathyroidism type 1 (PHP1a), caused by maternally inherited heterozygous mutations in <italic>GNAS</italic>. PHP1a is associated with the clinical phenotype of Albright's hereditary osteodystrophy (AHO), which encompasses short stature, round facies, and skeletal abnormalities<xref ref-type="ref" rid="obr12836-bib-0058">58</xref>
</p>
<p>Monogenic (non‐syndromic) causes of obesity are characterized by a young age of onset and hyperphagia,<xref ref-type="ref" rid="obr12836-bib-0012">12</xref>, <xref ref-type="ref" rid="obr12836-bib-0054">54</xref> with usually no intellectual deficit. Additionally, other clinical signs of monogenetic obesity may differ depending on the affected gene. These include red or ruddy hair, pale skin, and adrenocorticotropic hormone (ACTH) deficiency (pro‐opiomelanocortin [<italic>POMC</italic>] gene defects), central hypothyroidism, hypogonadotropic hypogonadism and frequent infections (leptin deficiency, caused by autosomal recessive <italic>LEP</italic> gene mutations), increased linear growth and increased lean mass, severe hyperinsulinemia, and mild central hypothyroidism (caused by autosomal dominant or recessive <italic>MC4R</italic> mutations) and neonatal diarrhea, recurrent hypoglycemia, and global endocrine dysfunction (caused by prohormone convertase‐1 [<italic>PCSK1</italic>] mutations).<xref ref-type="ref" rid="obr12836-bib-0054">54</xref>, <xref ref-type="ref" rid="obr12836-bib-0059">59</xref>
</p>
</sec>
<sec id="obr12836-sec-0010">
<label>3.4</label>
<title>Neuroendocrine causes</title>
<sec id="obr12836-sec-0011">
<label>3.4.1</label>
<title>Hormonal causes</title>
<p>A relatively sudden increase in weight may suggest a neuroendocrine cause. We screen for hypothyroidism, as this is associated with a modest weight gain. This is especially recommended if patients present with other symptoms such as dry skin, feeling cold, etc. However, the weight gain in hypothyroidism seems mostly due to additional edema.<xref ref-type="ref" rid="obr12836-bib-0060">60</xref> Also, obesity is often associated with a slightly increased TSH that is most often the result of excess adipose tissue rather than the cause of obesity. This can be explained by the presence of peripheral thyroid resistance and also by increased levels of leptin, stimulating TRH and subsequently TSH.<xref ref-type="ref" rid="obr12836-bib-0009">9</xref>, <xref ref-type="ref" rid="obr12836-bib-0010">10</xref> Weight loss usually reverses this form of hyperthyrotropinemia.<xref ref-type="ref" rid="obr12836-bib-0061">61</xref>
</p>
<p>To identify Cushing syndrome (CS), specific signs of CS including easy bruising, facial plethora, proximal myopathy, and recent purple striae<xref ref-type="ref" rid="obr12836-bib-0062">62</xref> should be considered, as most patients with obesity will have the more non‐specific CS signs such as central obesity, fatigue, hypertension, and decreased libido. Due to the large number of corticosteroid users,<xref ref-type="ref" rid="obr12836-bib-0063">63</xref>, <xref ref-type="ref" rid="obr12836-bib-0064">64</xref> iatrogenic CS should also be considered.</p>
<p>Another common endocrine condition associated with obesity is the polycystic ovarian syndrome (PCOS), a constellation of hyperandrogenism, oligoovulation or anovulation, and polycystic ovaries. Male hypogonadism has a complex, bidirectional relation with obesity. Testosterone therapy in patients with obesity or diabetes with evident testosterone deficiency causes improvement of body composition and components of the metabolic syndrome.<xref ref-type="ref" rid="obr12836-bib-0008">8</xref>, <xref ref-type="ref" rid="obr12836-bib-0065">65</xref> On the other hand, obesity induces hypogonadotropic hypogonadism, and a healthy diet and physical activity can increase bound and unbound testosterone levels and completely normalize the hypogonadism.<xref ref-type="ref" rid="obr12836-bib-0066">66</xref>
</p>
<p>Women may report weight gain after pregnancy<xref ref-type="ref" rid="obr12836-bib-0067">67</xref> or menopause.<xref ref-type="ref" rid="obr12836-bib-0068">68</xref> The average weight change from preconception to the first year postpartum is referred to as “postpartum weight retention.” This is on average relatively small (0.5 to 1.5 kg). However, there is a large variability, as 13% to 20% of women are 5 kg or more above their preconception weight by 1‐year postpartum.<xref ref-type="ref" rid="obr12836-bib-0069">69</xref> Although menopause is frequently reported as a contributing factor by women, and experimental evidence suggests estrogen depletion is associated with abdominal fat accumulation, epidemiological evidence in humans indicates that the steady weight gain of 0.5 kg annually is due to age rather than the menopause itself.<xref ref-type="ref" rid="obr12836-bib-0070">70</xref>
</p>
<p>In specific patients with a history of pituitary disease, surgery or irradiation in these areas, severe head trauma, or evidence of other pituitary hormone deficiencies,<xref ref-type="ref" rid="obr12836-bib-0071">71</xref> endocrine evaluation is indicated, including growth hormone (GH) deficiency as it may contribute to obesity and treatment options are available.<xref ref-type="ref" rid="obr12836-bib-0072">72</xref>, <xref ref-type="ref" rid="obr12836-bib-0073">73</xref>
</p>
</sec>
<sec id="obr12836-sec-0012">
<label>3.4.2</label>
<title>Hypothalamic disorders</title>
<p>Hypothalamic obesity, typically accompanied by hyperphagia, can occur after various insults leading to damage of the hypothalamic region. It is seen in patients with abnormalities in the hypothalamic region, eg, craniopharyngeoma (especially following surgery), inflammatory processes such as sarcoidosis and tuberculosis, vascular damage, head trauma, or after cranial radiotherapy, but also some of the genetic mutations that were previously mentioned can be considered hypothalamic obesity.<xref ref-type="ref" rid="obr12836-bib-0074">74</xref> In severe cases, it can lead to multiple endocrine symptoms such as impaired reproductive function with amenorrhea or impotence, diabetes insipidus, and thyroid or adrenal insufficiency (obesity that results in hormonal abnormalities is discussed in the previous paragraph). Also, neurological symptoms can be seen, including convulsions, hypothermia or hyperthermia, or somnolence.<xref ref-type="ref" rid="obr12836-bib-0075">75</xref>
</p>
</sec>
</sec>
<sec id="obr12836-sec-0013">
<label>3.5</label>
<title>Mental factors</title>
<p>In patients with obesity, attention to mental factors should be paid. Numerous studies showed that depression is linked to obesity, in a bidirectional manner.<xref ref-type="ref" rid="obr12836-bib-0076">76</xref>, <xref ref-type="ref" rid="obr12836-bib-0077">77</xref>, <xref ref-type="ref" rid="obr12836-bib-0078">78</xref> This is not surprising, as changes in food intake are considered symptoms of depression.<xref ref-type="ref" rid="obr12836-bib-0079">79</xref> The associations are stronger for patients with a symptom profile that is often labeled as “atypical.”<xref ref-type="ref" rid="obr12836-bib-0078">78</xref> Also, anxiety disorders are cross‐sectionally associated with obesity.<xref ref-type="ref" rid="obr12836-bib-0080">80</xref>
</p>
<p>Binge‐eating disorder<xref ref-type="ref" rid="obr12836-bib-0081">81</xref> is characterized by recurrent binge‐eating episodes where more food is consumed than is normal for most people and where feelings of lack of control and distress play a role. Importantly, binge‐eating can also be a sign of hyperphagia and may thus be a diagnostic clue for either genetic or hypothalamic obesity, as demonstrated in Clinical Case B.</p>
<p>Evidence is mounting that stress leads to more appetite (in comfort food), induces abdominal obesity,<xref ref-type="ref" rid="obr12836-bib-0024">24</xref> and may counteract the effects of a healthy diet.<xref ref-type="ref" rid="obr12836-bib-0082">82</xref>, <xref ref-type="ref" rid="obr12836-bib-0083">83</xref>, <xref ref-type="ref" rid="obr12836-bib-0084">84</xref> Additionally, the weight stigma that individuals with obesity often suffer from may also lead to extra weight gain.<xref ref-type="ref" rid="obr12836-bib-0085">85</xref> It is therefore conceivable that a non‐stigmatizing attitude, as well as stress reduction, is beneficial when treating obesity.</p>
<p>Furthermore, events during early life have been identified as risk factors for obesity. Adolescents with a history of childhood sexual abuse have a higher risk of obesity (in men) or disordered eating (in women)<xref ref-type="ref" rid="obr12836-bib-0086">86</xref>
</p>
</sec>
</sec>
<sec id="obr12836-sec-0014">
<label>4</label>
<title>LABORATORY DIAGNOSTICS AND FURTHER EVALUATION</title>
<p>General laboratory evaluation can be considered in all patients with obesity, including fasting glucose (and insulin in case of acanthosis nigricans), lipids, liver enzymes, and thyroid screening (TSH, and FT4 on indication).<xref ref-type="ref" rid="obr12836-bib-0005">5</xref> In case of clinical clues, this can be extended by testing gonadal function and/or Cushing diagnostics. Diagnostics for (mono)genetic obesity should be reserved for individuals with a high clinical suspicion (eg, early onset obesity, with or without intellectual deficit, dysmorphic features/congenital malformations, behavioral problems, hyperphagia, and/or striking family history, Figure <xref ref-type="fig" rid="obr12836-fig-0001">1</xref>, <xref ref-type="ref" rid="obr12836-bib-0053">53</xref>).</p>
</sec>
<sec id="obr12836-sec-0015">
<label>5</label>
<title>SOCIETY‐RELATED OBESOGENIC FACTORS AND FUTURE TARGETS FOR PUBLIC HEALTH INTERVENTIONS</title>
<p>The assessment of obesity can be complicated further by considering disruptors of energy homeostasis on a societal level. These currently have limited value in clinical practice but are interesting possible targets for public health interventions. These include endocrine disruptors, such as chemicals in pesticides/herbicides, industrial and household products, plastics, detergents, flame retardants, and ingredients in personal care products, that can affect the endocrine system and interfere with various metabolic processes.<xref ref-type="ref" rid="obr12836-bib-0087">87</xref>, <xref ref-type="ref" rid="obr12836-bib-0088">88</xref> In addition, both low birthweight and high birthweight in boys and high birth weight in girls have been associated to obesity,<xref ref-type="ref" rid="obr12836-bib-0089">89</xref> indicating that intra‐uterine factors may be important to weight. Also, early childhood infections have recently been shown to contribute to obesity.<xref ref-type="ref" rid="obr12836-bib-0090">90</xref> In this context, an interesting emerging field of research is “infectobesity,” which is the study of microbial agents as a cause of obesity. For example, intriguing associations between obesity and the adenovirus‐36 have been found.<xref ref-type="ref" rid="obr12836-bib-0091">91</xref> The changing gut microbiome seems more and more important in the pathogenesis of obesity.<xref ref-type="ref" rid="obr12836-bib-0092">92</xref>
</p>
</sec>
<sec id="obr12836-sec-0016">
<label>6</label>
<title>CONCLUSIONS</title>
<p>Obesity is a complex clinical problem where adequate diagnostics are often overlooked. We plead for a comprehensive approach of obesity, including adequate diagnostics prior to treatment. This includes, besides evaluation of lifestyle factors, a detailed past and present medical history, medication use, a global outline of the sociocultural environment, and a thorough physical examination. In case of abnormalities suggestive of an underlying disease, we recommend specific testing for these causes, as some conditions may be treatable. Furthermore, modifiable contributing factors, such as the use of weight gaining medication, lack of sleep, chronic stress etc. may be optimized before starting a lifestyle intervention or bariatric surgery. This may lead to more effective treatment for individuals with obesity. Additionally, knowing the cause of the obesity can help to reduce the social stigma that many individuals with obesity suffer from.</p>
</sec>
</body>
<back>
<ack id="obr12836-sec-0017">
<title>ACKNOWLEDGEMENTS</title>
<p>EFCvR is supported by a Vidi grant from the Netherlands Organization of Scientific Research NWO (grant number: 91716453). ELTvdA and EFCvR are funded by the Elisabeth Foundation.</p>
<p>We thank the patients whose history was written above and who gave permission to publish this article.</p>
</ack>
<ref-list content-type="cited-references" id="obr12836-bibl-0001">
<title>REFERENCES</title>
<ref id="obr12836-bib-0001">
<label>1</label>
<mixed-citation id="obr12836-cit-0002" publication-type="journal">
<string-name>
<surname>Bray</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>Wilding</surname>
<given-names>JPH</given-names>
</string-name>, <string-name>
<surname>World</surname>
<given-names>OF</given-names>
</string-name>. <article-title>Obesity: a chronic relapsing progressive disease process. A position statement of the World obesity federation</article-title>. <source xml:lang="en"/>Obes Rev. <year>2017</year>;<volume>18</volume>(<issue>7</issue>):<fpage>715</fpage>‐<lpage>723</lpage>.<pub-id pub-id-type="pmid">28489290</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0002">
<label>2</label>
<mixed-citation id="obr12836-cit-0003" publication-type="miscellaneous">
<collab collab-type="authors">World Health Organisation</collab>
. <article-title>Obesity and Overweight fact sheet</article-title>. june 2016 <year>2016</year>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0003">
<label>3</label>
<mixed-citation id="obr12836-cit-0004" publication-type="journal">
<collab collab-type="authors">Collaborators GBDO</collab>
. <article-title>Health effects of overweight and obesity in 195 countries over 25 years</article-title>. <source xml:lang="en"/>N Engl J Med. <year>2017</year>;<volume>377</volume>:<fpage>13</fpage>‐<lpage>17</lpage>.<pub-id pub-id-type="pmid">28604169</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0004">
<label>4</label>
<mixed-citation id="obr12836-cit-0005" publication-type="journal">
<string-name>
<surname>Whelton</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Carey</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Aronow</surname>
<given-names>WS</given-names>
</string-name>, et al. <article-title>2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines</article-title>. <source xml:lang="en"/>Hypertension. <year>2018</year>;<volume>71</volume>(<issue>6</issue>):<fpage>e13</fpage>‐<lpage>e115</lpage>.<pub-id pub-id-type="pmid">29133356</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0005">
<label>5</label>
<mixed-citation id="obr12836-cit-0006" publication-type="journal">
<string-name>
<surname>Yumuk</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Tsigos</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Fried</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>European guidelines for obesity management in adults</article-title>. <source xml:lang="en"/>Obes Facts. <year>2015</year>;<volume>8</volume>(<issue>6</issue>):<fpage>402</fpage>‐<lpage>424</lpage>.<pub-id pub-id-type="pmid">26641646</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0006">
<label>6</label>
<mixed-citation id="obr12836-cit-0007" publication-type="journal">
<string-name>
<surname>Garvey</surname>
<given-names>WT</given-names>
</string-name>, <string-name>
<surname>Mechanick</surname>
<given-names>JI</given-names>
</string-name>, <string-name>
<surname>Brett</surname>
<given-names>EM</given-names>
</string-name>, et al. <article-title>American Association of Clinical Endocrinologists and American College of endocrinology comprehensive clinical practice guidelines for medical Care of Patients with obesity</article-title>. <source xml:lang="en"/>Endocr Pract. <year>2016</year>;<volume>22</volume>(<issue>Suppl 3</issue>):<fpage>1</fpage>‐<lpage>203</lpage>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0007">
<label>7</label>
<mixed-citation id="obr12836-cit-0008" publication-type="journal">
<string-name>
<surname>Jensen</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Ryan</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Apovian</surname>
<given-names>CM</given-names>
</string-name>, et al. <article-title>2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society</article-title>. <source xml:lang="en"/>Circulation. <year>2014</year>;<volume>129</volume>(<issue>25 Suppl 2</issue>):<fpage>S102</fpage>‐<lpage>S138</lpage>.<pub-id pub-id-type="pmid">24222017</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0008">
<label>8</label>
<mixed-citation id="obr12836-cit-0009" publication-type="journal">
<string-name>
<surname>Saad</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Yassin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Doros</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Haider</surname>
<given-names>A</given-names>
</string-name>. <article-title>Effects of long‐term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I‐III: observational data from two registry studies</article-title>. <source xml:lang="en"/>Int J Obes (Lond). <year>2016</year>;<volume>40</volume>(<issue>1</issue>):<fpage>162</fpage>‐<lpage>170</lpage>.<pub-id pub-id-type="pmid">26219417</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0009">
<label>9</label>
<mixed-citation id="obr12836-cit-0010" publication-type="journal">
<string-name>
<surname>Biondi</surname>
<given-names>B</given-names>
</string-name>. <article-title>Thyroid and obesity: an intriguing relationship</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metab. <year>2010</year>;<volume>95</volume>(<issue>8</issue>):<fpage>3614</fpage>‐<lpage>3617</lpage>.<pub-id pub-id-type="pmid">20685890</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0010">
<label>10</label>
<mixed-citation id="obr12836-cit-0011" publication-type="journal">
<string-name>
<surname>Sanyal</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Raychaudhuri</surname>
<given-names>M</given-names>
</string-name>. <article-title>Hypothyroidism and obesity: an intriguing link</article-title>. <source xml:lang="en"/>Indian J Endocrinol Metab. <year>2016</year>;<volume>20</volume>(<issue>4</issue>):<fpage>554</fpage>‐<lpage>557</lpage>.<pub-id pub-id-type="pmid">27366725</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0011">
<label>11</label>
<mixed-citation id="obr12836-cit-0012" publication-type="journal">
<string-name>
<surname>Hainerova</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Lebl</surname>
<given-names>J</given-names>
</string-name>. <article-title>Treatment options for children with monogenic forms of obesity</article-title>. <source xml:lang="en"/>World Rev Nutr Diet. <year>2013</year>;<volume>106</volume>:<fpage>105</fpage>‐<lpage>112</lpage>.<pub-id pub-id-type="pmid">23428688</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0012">
<label>12</label>
<mixed-citation id="obr12836-cit-0013" publication-type="book">
<string-name>
<surname>Alsters</surname>
<given-names>S</given-names>
</string-name>. <source xml:lang="en"/>Genetic Analysis of Extreme Obesity. <publisher-loc>London</publisher-loc>: <publisher-name>Department of Medicine, Imperial College London</publisher-name>; <year>2016</year>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0013">
<label>13</label>
<mixed-citation id="obr12836-cit-0014" publication-type="journal">
<string-name>
<surname>Fani</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bak</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Delhanty</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>van Rossum</surname>
<given-names>EF</given-names>
</string-name>, <string-name>
<surname>van den Akker</surname>
<given-names>EL</given-names>
</string-name>. <article-title>The melanocortin‐4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options</article-title>. <source xml:lang="en"/>Int J Obes (Lond). <year>2014</year>;<volume>38</volume>(<issue>2</issue>):<fpage>163</fpage>‐<lpage>169</lpage>.<pub-id pub-id-type="pmid">23774329</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0014">
<label>14</label>
<mixed-citation id="obr12836-cit-0015" publication-type="journal">
<string-name>
<surname>Kühnen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Clément</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wiegand</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Proopiomelanocortin deficiency treated with a melanocortin‐4 receptor agonist</article-title>. <source xml:lang="en"/>N Engl J Med. <year>2016</year>;<volume>375</volume>(<issue>3</issue>):<fpage>240</fpage>‐<lpage>246</lpage>.<pub-id pub-id-type="pmid">27468060</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0015">
<label>15</label>
<mixed-citation id="obr12836-cit-0016" publication-type="journal">
<string-name>
<surname>Sharma</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Padwal</surname>
<given-names>R</given-names>
</string-name>. <article-title>Obesity is a sign―over‐eating is a symptom: an aetiological framework for the assessment and management of obesity</article-title>. <source xml:lang="en"/>Obes Rev. <year>2010</year>;<volume>11</volume>(<issue>5</issue>):<fpage>362</fpage>‐<lpage>370</lpage>.<pub-id pub-id-type="pmid">19922430</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0016">
<label>16</label>
<mixed-citation id="obr12836-cit-0017" publication-type="journal">
<string-name>
<surname>Romieu</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Dossus</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Barquera</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Energy balance and obesity: what are the main drivers?</article-title>
<source xml:lang="en"/>Cancer Causes Control. <year>2017</year>;<volume>28</volume>(<issue>3</issue>):<fpage>247</fpage>‐<lpage>258</lpage>.<pub-id pub-id-type="pmid">28210884</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0017">
<label>17</label>
<mixed-citation id="obr12836-cit-0018" publication-type="journal">
<string-name>
<surname>Heymsfield</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Harp</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Reitman</surname>
<given-names>ML</given-names>
</string-name>, et al. <article-title>Why do obese patients not lose more weight when treated with low‐calorie diets? A mechanistic perspective</article-title>. <source xml:lang="en"/>Am J Clin Nutr. <year>2007</year>;<volume>85</volume>(<issue>2</issue>):<fpage>346</fpage>‐<lpage>354</lpage>.<pub-id pub-id-type="pmid">17284728</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0018">
<label>18</label>
<mixed-citation id="obr12836-cit-0019" publication-type="journal">
<string-name>
<surname>Macht</surname>
<given-names>M</given-names>
</string-name>. <article-title>How emotions affect eating: a five‐way model</article-title>. <source xml:lang="en"/>Appetite. <year>2008</year>;<volume>50</volume>(<issue>1</issue>):<fpage>1</fpage>‐<lpage>11</lpage>.<pub-id pub-id-type="pmid">17707947</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0019">
<label>19</label>
<mixed-citation id="obr12836-cit-0020" publication-type="journal">
<string-name>
<surname>Cappuccio</surname>
<given-names>FP</given-names>
</string-name>, <string-name>
<surname>Taggart</surname>
<given-names>FM</given-names>
</string-name>, <string-name>
<surname>Kandala</surname>
<given-names>NB</given-names>
</string-name>, et al. <article-title>Meta‐analysis of short sleep duration and obesity in children and adults</article-title>. <source xml:lang="en"/>Sleep. <year>2008</year>;<volume>31</volume>(<issue>5</issue>):<fpage>619</fpage>‐<lpage>626</lpage>.<pub-id pub-id-type="pmid">18517032</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0020">
<label>20</label>
<mixed-citation id="obr12836-cit-0021" publication-type="journal">
<string-name>
<surname>Patel</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>FB</given-names>
</string-name>. <article-title>Short sleep duration and weight gain: a systematic review</article-title>. <source xml:lang="en"/>Obesity (Silver Spring). <year>2008</year>;<volume>16</volume>(<issue>3</issue>):<fpage>643</fpage>‐<lpage>653</lpage>.<pub-id pub-id-type="pmid">18239586</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0021">
<label>21</label>
<mixed-citation id="obr12836-cit-0022" publication-type="journal">
<string-name>
<surname>Bayon</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Leger</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gomez‐Merino</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Vecchierini</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Chennaoui</surname>
<given-names>M</given-names>
</string-name>. <article-title>Sleep debt and obesity</article-title>. <source xml:lang="en"/>Ann Med. <year>2014</year>;<volume>46</volume>(<issue>5</issue>):<fpage>264</fpage>‐<lpage>272</lpage>.<pub-id pub-id-type="pmid">25012962</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0022">
<label>22</label>
<mixed-citation id="obr12836-cit-0023" publication-type="journal">
<string-name>
<surname>Minkel</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Moreta</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Muto</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Sleep deprivation potentiates HPA axis stress reactivity in healthy adults</article-title>. <source xml:lang="en"/>Health Psychol. <year>2014</year>;<volume>33</volume>(<issue>11</issue>):<fpage>1430</fpage>‐<lpage>1434</lpage>.<pub-id pub-id-type="pmid">24818608</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0023">
<label>23</label>
<mixed-citation id="obr12836-cit-0024" publication-type="journal">
<string-name>
<surname>Manenschijn</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Van Kruysbergen</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>De Jong</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Koper</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Lamberts</surname>
<given-names>SWJ</given-names>
</string-name>, <string-name>
<surname>Van Rossum</surname>
<given-names>EFC</given-names>
</string-name>. <article-title>Shift work at young age is associated with elevated long‐term cortisol levels and body mass index</article-title>. <source xml:lang="en"/>Endocr Rev. <year>2012</year>;<volume>33</volume>(<issue>3</issue>):<fpage>E1862</fpage>‐<lpage>E1865</lpage>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0024">
<label>24</label>
<mixed-citation id="obr12836-cit-0025" publication-type="journal">
<string-name>
<surname>van der Valk</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Savas</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>van Rossum</surname>
<given-names>EFC</given-names>
</string-name>. <article-title>Stress and obesity: are there more susceptible individuals?</article-title>
<source xml:lang="en"/>Curr Obes Rep. <year>2018</year>;<volume>7</volume>(<issue>2</issue>):<fpage>193</fpage>‐<lpage>203</lpage>.<pub-id pub-id-type="pmid">29663153</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0025">
<label>25</label>
<mixed-citation id="obr12836-cit-0026" publication-type="journal">
<string-name>
<surname>Broussard</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Van Cauter</surname>
<given-names>E</given-names>
</string-name>. <article-title>Disturbances of sleep and circadian rhythms: novel risk factors for obesity</article-title>. <source xml:lang="en"/>Curr Opin Endocrinol Diabetes Obes. <year>2016</year>;<volume>23</volume>(<issue>5</issue>):<fpage>353</fpage>‐<lpage>359</lpage>.<pub-id pub-id-type="pmid">27584008</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0026">
<label>26</label>
<mixed-citation id="obr12836-cit-0027" publication-type="journal">
<string-name>
<surname>McHill</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>KP</given-names>
<suffix>Jr</suffix>
</string-name>. <article-title>Role of sleep and circadian disruption on energy expenditure and in metabolic predisposition to human obesity and metabolic disease</article-title>. <source xml:lang="en"/>Obes Rev. <year>2017</year>;<volume>18</volume>(<issue>Suppl 1</issue>):<fpage>15</fpage>‐<lpage>24</lpage>.<pub-id pub-id-type="pmid">28164449</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0027">
<label>27</label>
<mixed-citation id="obr12836-cit-0028" publication-type="journal">
<string-name>
<surname>St‐Onge</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Shechter</surname>
<given-names>A</given-names>
</string-name>. <article-title>Sleep disturbances, body fat distribution, food intake and/or energy expenditure: pathophysiological aspects</article-title>. <source xml:lang="en"/>Horm Mol Biol Clin Invest. <year>2014</year>;<volume>17</volume>(<issue>1</issue>):<fpage>29</fpage>‐<lpage>37</lpage>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0028">
<label>28</label>
<mixed-citation id="obr12836-cit-0029" publication-type="journal">
<string-name>
<surname>Shechter</surname>
<given-names>A</given-names>
</string-name>. <article-title>Effects of continuous positive airway pressure on energy balance regulation: a systematic review</article-title>. <source xml:lang="en"/>Eur Respir J. <year>2016</year>;<volume>48</volume>(<issue>6</issue>):<fpage>1640</fpage>‐<lpage>1657</lpage>.<pub-id pub-id-type="pmid">27824596</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0029">
<label>29</label>
<mixed-citation id="obr12836-cit-0030" publication-type="journal">
<string-name>
<surname>Shechter</surname>
<given-names>A</given-names>
</string-name>. <article-title>Obstructive sleep apnea and energy balance regulation: a systematic review</article-title>. <source xml:lang="en"/>Sleep Med Rev. <year>2017</year>;<volume>34</volume>:<fpage>59</fpage>‐<lpage>69</lpage>.<pub-id pub-id-type="pmid">27818084</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0030">
<label>30</label>
<mixed-citation id="obr12836-cit-0031" publication-type="journal">
<string-name>
<surname>Drager</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>Brunoni</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Jenner</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lorenzi‐Filho</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bensenor</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Lotufo</surname>
<given-names>PA</given-names>
</string-name>. <article-title>Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta‐analysis of randomised trials</article-title>. <source xml:lang="en"/>Thorax. <year>2015</year>;<volume>70</volume>(<issue>3</issue>):<fpage>258</fpage>‐<lpage>264</lpage>.<pub-id pub-id-type="pmid">25432944</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0031">
<label>31</label>
<mixed-citation id="obr12836-cit-0032" publication-type="journal">
<string-name>
<surname>Nymo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Coutinho</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Torgersen</surname>
<given-names>LH</given-names>
</string-name>, et al. <article-title>Timeline of changes in adaptive physiological responses, at the level of energy expenditure, with progressive weight loss</article-title>. <source xml:lang="en"/>Br J Nutr. <year>2018</year>;<volume>120</volume>(<issue>2</issue>):<fpage>141</fpage>‐<lpage>149</lpage>.<pub-id pub-id-type="pmid">29733003</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0032">
<label>32</label>
<mixed-citation id="obr12836-cit-0033" publication-type="journal">
<string-name>
<surname>Myers</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gibbons</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Finlayson</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Blundell</surname>
<given-names>J</given-names>
</string-name>. <article-title>Associations among sedentary and active behaviours, body fat and appetite dysregulation: investigating the myth of physical inactivity and obesity</article-title>. <source xml:lang="en"/>Br J Sports Med. <year>2017</year>;<volume>51</volume>(<issue>21</issue>):<fpage>1540</fpage>‐<lpage>1544</lpage>.<pub-id pub-id-type="pmid">27044438</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0033">
<label>33</label>
<mixed-citation id="obr12836-cit-0034" publication-type="journal">
<string-name>
<surname>Villablanca</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Alegria</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Mookadam</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Holmes</surname>
<given-names>DR</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Levine</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Nonexercise activity thermogenesis in obesity management</article-title>. <source xml:lang="en"/>Mayo Clin Proc. <year>2015</year>;<volume>90</volume>(<issue>4</issue>):<fpage>509</fpage>‐<lpage>519</lpage>.<pub-id pub-id-type="pmid">25841254</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0034">
<label>34</label>
<mixed-citation id="obr12836-cit-0035" publication-type="journal">
<string-name>
<surname>Kim</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Plutzky</surname>
<given-names>J</given-names>
</string-name>. <article-title>Brown fat and browning for the treatment of obesity and related metabolic disorders</article-title>. <source xml:lang="en"/>Diabetes Metab J. <year>2016</year>;<volume>40</volume>(<issue>1</issue>):<fpage>12</fpage>‐<lpage>21</lpage>.<pub-id pub-id-type="pmid">26912151</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0035">
<label>35</label>
<mixed-citation id="obr12836-cit-0036" publication-type="journal">
<string-name>
<surname>Yoneshiro</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Aita</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Matsushita</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Recruited brown adipose tissue as an antiobesity agent in humans</article-title>. <source xml:lang="en"/>J Clin Invest. <year>2013</year>;<volume>123</volume>(<issue>8</issue>):<fpage>3404</fpage>‐<lpage>3408</lpage>.<pub-id pub-id-type="pmid">23867622</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0036">
<label>36</label>
<mixed-citation id="obr12836-cit-0037" publication-type="journal">
<string-name>
<surname>Harris</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>Zopey</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Friedman</surname>
<given-names>TC</given-names>
</string-name>. <article-title>Metabolic effects of smoking cessation</article-title>. <source xml:lang="en"/>Nat Rev Endocrinol. <year>2016</year>;<volume>12</volume>(<issue>5</issue>):<fpage>299</fpage>‐<lpage>308</lpage>.<pub-id pub-id-type="pmid">26939981</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0037">
<label>37</label>
<mixed-citation id="obr12836-cit-0038" publication-type="journal">
<string-name>
<surname>Bush</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lovejoy</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Deprey</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Carpenter</surname>
<given-names>KM</given-names>
</string-name>. <article-title>The effect of tobacco cessation on weight gain, obesity, and diabetes risk</article-title>. <source xml:lang="en"/>Obesity (Silver Spring). <year>2016</year>;<volume>24</volume>(<issue>9</issue>):<fpage>1834</fpage>‐<lpage>1841</lpage>.<pub-id pub-id-type="pmid">27569117</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0038">
<label>38</label>
<mixed-citation id="obr12836-cit-0039" publication-type="journal">
<string-name>
<surname>Apovian</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Aronne</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Bessesen</surname>
<given-names>DH</given-names>
</string-name>, et al. <article-title>Pharmacological management of obesity: an endocrine society clinical practice guideline</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metab. <year>2015</year>;<volume>100</volume>(<issue>2</issue>):<fpage>342</fpage>‐<lpage>362</lpage>.<pub-id pub-id-type="pmid">25590212</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0039">
<label>39</label>
<mixed-citation id="obr12836-cit-0040" publication-type="journal">
<string-name>
<surname>Serretti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mandelli</surname>
<given-names>L</given-names>
</string-name>. <article-title>Antidepressants and body weight: a comprehensive review and meta‐analysis</article-title>. <source xml:lang="en"/>J Clin Psychiatry. <year>2010</year>;<volume>71</volume>(<issue>10</issue>):<fpage>1259</fpage>‐<lpage>1272</lpage>.<pub-id pub-id-type="pmid">21062615</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0040">
<label>40</label>
<mixed-citation id="obr12836-cit-0041" publication-type="journal">
<string-name>
<surname>Allison</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Casey</surname>
<given-names>DE</given-names>
</string-name>. <article-title>Antipsychotic‐induced weight gain: a review of the literature</article-title>. <source xml:lang="en"/>J Clin Psychiatry. <year>2001</year>;<volume>62</volume>(<issue>Suppl 7</issue>):<fpage>22</fpage>‐<lpage>31</lpage>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0041">
<label>41</label>
<mixed-citation id="obr12836-cit-0042" publication-type="journal">
<string-name>
<surname>Da Silva</surname>
<given-names>JAP</given-names>
</string-name>, <string-name>
<surname>Jacobs</surname>
<given-names>JWG</given-names>
</string-name>, <string-name>
<surname>Kirwan</surname>
<given-names>JR</given-names>
</string-name>, et al. <article-title>Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data</article-title>. <source xml:lang="en"/>Ann Rheum Dis. <year>2006</year>;<volume>65</volume>(<issue>3</issue>):<fpage>285</fpage>‐<lpage>293</lpage>.<pub-id pub-id-type="pmid">16107513</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0042">
<label>42</label>
<mixed-citation id="obr12836-cit-0043" publication-type="journal">
<string-name>
<surname>Savas</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Muka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Wester</surname>
<given-names>VL</given-names>
</string-name>, et al. <article-title>Associations between systemic and local corticosteroid use with metabolic syndrome and body mass index</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metab. <year>2017</year>;<volume>102</volume>(<issue>10</issue>):<fpage>3765</fpage>‐<lpage>3774</lpage>.<pub-id pub-id-type="pmid">28973553</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0043">
<label>43</label>
<mixed-citation id="obr12836-cit-0044" publication-type="journal">
<string-name>
<surname>Broersen</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Pereira</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Jorgensen</surname>
<given-names>JO</given-names>
</string-name>, <string-name>
<surname>Dekkers</surname>
<given-names>OM</given-names>
</string-name>. <article-title>Adrenal insufficiency in corticosteroids use: systematic review and meta‐analysis</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metab. <year>2015</year>;<volume>100</volume>(<issue>6</issue>):<fpage>2171</fpage>‐<lpage>2180</lpage>.<pub-id pub-id-type="pmid">25844620</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0044">
<label>44</label>
<mixed-citation id="obr12836-cit-0045" publication-type="journal">
<string-name>
<surname>Sharma</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Pischon</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hardt</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kunz</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Luft</surname>
<given-names>FC</given-names>
</string-name>. <article-title>Hypothesis: beta‐adrenergic receptor blockers and weight gain: a systematic analysis</article-title>. <source xml:lang="en"/>Hypertension. <year>2001</year>;<volume>37</volume>(<issue>2</issue>):<fpage>250</fpage>‐<lpage>254</lpage>.<pub-id pub-id-type="pmid">11230280</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0045">
<label>45</label>
<mixed-citation id="obr12836-cit-0046" publication-type="journal">
<string-name>
<surname>Messerli</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Bell</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Fonseca</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Body weight changes with beta‐blocker use: results from GEMINI</article-title>. <source xml:lang="en"/>Am J Med. <year>2007</year>;<volume>120</volume>(<issue>7</issue>):<fpage>610</fpage>‐<lpage>615</lpage>.<pub-id pub-id-type="pmid">17602935</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0046">
<label>46</label>
<mixed-citation id="obr12836-cit-0047" publication-type="journal">
<string-name>
<surname>Manrique</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Whaley‐Connell</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sowers</surname>
<given-names>JR</given-names>
</string-name>. <article-title>Nebivolol in obese and non‐obese hypertensive patients</article-title>. <source xml:lang="en"/>J Clin Hypertens (Greenwich). <year>2009</year>;<volume>11</volume>(<issue>6</issue>):<fpage>309</fpage>‐<lpage>315</lpage>.<pub-id pub-id-type="pmid">19527321</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0047">
<label>47</label>
<mixed-citation id="obr12836-cit-0048" publication-type="journal">
<string-name>
<surname>Ratliff</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Barber</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Palmese</surname>
<given-names>LB</given-names>
</string-name>, <string-name>
<surname>Reutenauer</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Tek</surname>
<given-names>C</given-names>
</string-name>. <article-title>Association of prescription H1 antihistamine use with obesity: results from the National Health and nutrition examination survey</article-title>. <source xml:lang="en"/>Obesity (Silver Spring). <year>2010</year>;<volume>18</volume>(<issue>12</issue>):<fpage>2398</fpage>‐<lpage>2400</lpage>.<pub-id pub-id-type="pmid">20706200</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0048">
<label>48</label>
<mixed-citation id="obr12836-cit-0049" publication-type="journal">
<string-name>
<surname>Gallo</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Lopez</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Grimes</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Carayon</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Schulz</surname>
<given-names>KF</given-names>
</string-name>, <string-name>
<surname>Helmerhorst</surname>
<given-names>FM</given-names>
</string-name>. <article-title>Combination contraceptives: effects on weight</article-title>. <source xml:lang="en"/>Cochrane Database Syst Rev. <year>2014</year>;<volume>1</volume> CD003987. <pub-id pub-id-type="doi">10.1002/14651858.CD003987.pub5</pub-id>
</mixed-citation>
</ref>
<ref id="obr12836-bib-0049">
<label>49</label>
<mixed-citation id="obr12836-cit-0050" publication-type="journal">
<string-name>
<surname>Cheskin</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Bartlett</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Zayas</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Twilley</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Allison</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Contoreggi</surname>
<given-names>C</given-names>
</string-name>. <article-title>Prescription medications: a modifiable contributor to obesity</article-title>. <source xml:lang="en"/>South Med J. <year>1999</year>;<volume>92</volume>(<issue>9</issue>):<fpage>898</fpage>‐<lpage>904</lpage>.<pub-id pub-id-type="pmid">10498166</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0050">
<label>50</label>
<mixed-citation id="obr12836-cit-0051" publication-type="journal">
<string-name>
<surname>Yoshikawa</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Nagato</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yamasaki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kume</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Otsuki</surname>
<given-names>M</given-names>
</string-name>. <article-title>Long‐term treatment with proton pump inhibitor is associated with undesired weight gain</article-title>. <source xml:lang="en"/>World J Gastroenterol. <year>2009</year>;<volume>15</volume>(<issue>38</issue>):<fpage>4794</fpage>‐<lpage>4798</lpage>.<pub-id pub-id-type="pmid">19824113</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0051">
<label>51</label>
<mixed-citation id="obr12836-cit-0052" publication-type="journal">
<string-name>
<surname>Ehrlich</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Friedenberg</surname>
<given-names>FK</given-names>
</string-name>. <article-title>Genetic associations of obesity: the fat‐mass and obesity‐associated (FTO) gene</article-title>. <source xml:lang="en"/>Clin Transl Gastroenterol. <year>2016</year>;<volume>7</volume>(<issue>1</issue>):<fpage>e140</fpage>.<pub-id pub-id-type="pmid">26821195</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0052">
<label>52</label>
<mixed-citation id="obr12836-cit-0053" publication-type="journal">
<string-name>
<surname>Bays</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Scinta</surname>
<given-names>W</given-names>
</string-name>. <article-title>Adiposopathy and epigenetics: an introduction to obesity as a transgenerational disease</article-title>. <source xml:lang="en"/>Curr Med Res Opin. <year>2015</year>;<volume>31</volume>(<issue>11</issue>):<fpage>2059</fpage>‐<lpage>2069</lpage>.<pub-id pub-id-type="pmid">26331354</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0053">
<label>53</label>
<mixed-citation id="obr12836-cit-0054" publication-type="journal">
<string-name>
<surname>Kleinendorst</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Massink</surname>
<given-names>MPG</given-names>
</string-name>, <string-name>
<surname>Cooiman</surname>
<given-names>MI</given-names>
</string-name>, et al. <article-title>Genetic obesity: next‐generation sequencing results of 1230 patients with obesity</article-title>. <source xml:lang="en"/>J Med Genet. <year>2018</year>;<volume>55</volume>(<issue>9</issue>):<fpage>578</fpage>‐<lpage>586</lpage>.<pub-id pub-id-type="pmid">29970488</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0054">
<label>54</label>
<mixed-citation id="obr12836-cit-0055" publication-type="journal">
<string-name>
<surname>Farooqi</surname>
<given-names>IS</given-names>
</string-name>. <article-title>The severely obese patient—a genetic work‐up</article-title>. <source xml:lang="en"/>Nat Clin Pract Endocrinol Metab. <year>2006</year>;<volume>2</volume>(<issue>3</issue>):<fpage>172</fpage>‐<lpage>177</lpage>.<pub-id pub-id-type="pmid">16932276</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0055">
<label>55</label>
<mixed-citation id="obr12836-cit-0056" publication-type="journal">
<string-name>
<surname>Styne</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Arslanian</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Connor</surname>
<given-names>EL</given-names>
</string-name>, et al. <article-title>Pediatric obesity—assessment, treatment, and prevention: an Endocrine Society clinical practice guideline</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metabol. <year>2017</year>;<volume>102</volume>(<issue>6</issue>):<fpage>2123</fpage>‐<lpage>2124</lpage>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0056">
<label>56</label>
<mixed-citation id="obr12836-cit-0057" publication-type="journal">
<string-name>
<surname>Holm</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Cassidy</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Butler</surname>
<given-names>MG</given-names>
</string-name>, et al. <article-title>Prader‐Willi syndrome: consensus diagnostic criteria</article-title>. <source xml:lang="en"/>Pediatrics. <year>1993</year>;<volume>91</volume>(<issue>2</issue>):<fpage>398</fpage>‐<lpage>402</lpage>.<pub-id pub-id-type="pmid">8424017</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0057">
<label>57</label>
<mixed-citation id="obr12836-cit-0058" publication-type="book">
<string-name>
<surname>Miller</surname>
<given-names>DT</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Nasir</surname>
<given-names>R</given-names>
</string-name>. <chapter-title>16p11.2 Recurrent Microdeletion</chapter-title> In: <person-group person-group-type="editor"><name name-style="western"><surname>Pagon</surname><given-names>RA</given-names></name></person-group>, <person-group person-group-type="editor"><name name-style="western"><surname>Adam</surname><given-names>MP</given-names></name></person-group>, <person-group person-group-type="editor"><name name-style="western"><surname>Ardinger</surname><given-names>HH</given-names></name></person-group>, et al., eds. <source xml:lang="en"/>GeneReviews®. <publisher-loc>WA</publisher-loc>: <publisher-name>University of Washington, Seattle</publisher-name>; <year>2015</year> [Updated 2015 Dec 10] ed.</mixed-citation>
</ref>
<ref id="obr12836-bib-0058">
<label>58</label>
<mixed-citation id="obr12836-cit-0059" publication-type="miscellaneous">
<string-name>
<surname>Haldeman‐Englert</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Hurst</surname>
<given-names>ACE</given-names>
</string-name>, <string-name>
<surname>Levine</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Disorders of GNAS Inactivation</article-title>. <year>1993</year>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0059">
<label>59</label>
<mixed-citation id="obr12836-cit-0060" publication-type="journal">
<string-name>
<surname>Farooqi</surname>
<given-names>IS</given-names>
</string-name>, <string-name>
<surname>Keogh</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Yeo</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Lank</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Cheetham</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>O'Rahilly</surname>
<given-names>S</given-names>
</string-name>. <article-title>Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene</article-title>. <source xml:lang="en"/>N Engl J Med. <year>2003</year>;<volume>348</volume>(<issue>12</issue>):<fpage>1085</fpage>‐<lpage>1095</lpage>.<pub-id pub-id-type="pmid">12646665</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0060">
<label>60</label>
<mixed-citation id="obr12836-cit-0061" publication-type="journal">
<string-name>
<surname>Laurberg</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Knudsen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Andersen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Carle</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pedersen</surname>
<given-names>IB</given-names>
</string-name>, <string-name>
<surname>Karmisholt</surname>
<given-names>J</given-names>
</string-name>. <article-title>Thyroid function and obesity</article-title>. <source xml:lang="en"/>Eur Thyroid J. <year>2012</year>;<volume>1</volume>(<issue>3</issue>):<fpage>159</fpage>‐<lpage>167</lpage>.<pub-id pub-id-type="pmid">24783015</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0061">
<label>61</label>
<mixed-citation id="obr12836-cit-0062" publication-type="journal">
<string-name>
<surname>Reinehr</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>de Sousa</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Andler</surname>
<given-names>W</given-names>
</string-name>. <article-title>Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metab. <year>2006</year>;<volume>91</volume>(<issue>8</issue>):<fpage>3088</fpage>‐<lpage>3091</lpage>.<pub-id pub-id-type="pmid">16684827</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0062">
<label>62</label>
<mixed-citation id="obr12836-cit-0063" publication-type="journal">
<string-name>
<surname>Nieman</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Biller</surname>
<given-names>BM</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>JW</given-names>
</string-name>, et al. <article-title>The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metab. <year>2008</year>;<volume>93</volume>(<issue>5</issue>):<fpage>1526</fpage>‐<lpage>1540</lpage>.<pub-id pub-id-type="pmid">18334580</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0063">
<label>63</label>
<mixed-citation id="obr12836-cit-0064" publication-type="journal">
<string-name>
<surname>Savas</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wester</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Staufenbiel</surname>
<given-names>SM</given-names>
</string-name>, et al. <article-title>Systematic evaluation of corticosteroid use in obese and non‐obese individuals: a multi‐cohort study</article-title>. <source xml:lang="en"/>Int J Med Sci. <year>2017</year>;<volume>14</volume>(<issue>7</issue>):<fpage>615</fpage>‐<lpage>621</lpage>.<pub-id pub-id-type="pmid">28824292</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0064">
<label>64</label>
<mixed-citation id="obr12836-cit-0065" publication-type="journal">
<string-name>
<surname>Savas</surname>
<given-names>MMT</given-names>
</string-name>, <string-name>
<surname>Wester</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>van den Akker</surname>
<given-names>ELT</given-names>
</string-name>, et al. <article-title>Associations between systemic and local corticosteroid use with metabolic syndrome and body mass index</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metabol. <year>2017</year>;<volume>102</volume>(<issue>10</issue>):<fpage>3765</fpage>‐<lpage>3774</lpage>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0065">
<label>65</label>
<mixed-citation id="obr12836-cit-0066" publication-type="journal">
<string-name>
<surname>Kapoor</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Goodwin</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Channer</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>TH</given-names>
</string-name>. <article-title>Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes</article-title>. <source xml:lang="en"/>Eur J Endocrinol. <year>2006</year>;<volume>154</volume>(<issue>6</issue>):<fpage>899</fpage>‐<lpage>906</lpage>.<pub-id pub-id-type="pmid">16728551</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0066">
<label>66</label>
<mixed-citation id="obr12836-cit-0067" publication-type="journal">
<string-name>
<surname>Corona</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rastrelli</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Monami</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Body weight loss reverts obesity‐associated hypogonadotropic hypogonadism: a systematic review and meta‐analysis</article-title>. <source xml:lang="en"/>Eur J Endocrinol. <year>2013</year>;<volume>168</volume>(<issue>6</issue>):<fpage>829</fpage>‐<lpage>843</lpage>.<pub-id pub-id-type="pmid">23482592</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0067">
<label>67</label>
<mixed-citation id="obr12836-cit-0068" publication-type="journal">
<string-name>
<surname>Gunderson</surname>
<given-names>EP</given-names>
</string-name>, <string-name>
<surname>Sternfeld</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Wellons</surname>
<given-names>MF</given-names>
</string-name>, et al. <article-title>Childbearing may increase visceral adipose tissue independent of overall increase in body fat</article-title>. <source xml:lang="en"/>Obesity (Silver Spring). <year>2008</year>;<volume>16</volume>(<issue>5</issue>):<fpage>1078</fpage>‐<lpage>1084</lpage>.<pub-id pub-id-type="pmid">18356843</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0068">
<label>68</label>
<mixed-citation id="obr12836-cit-0069" publication-type="journal">
<string-name>
<surname>Sowers</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tomey</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Changes in body composition in women over six years at midlife: ovarian and chronological aging</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metab. <year>2007</year>;<volume>92</volume>(<issue>3</issue>):<fpage>895</fpage>‐<lpage>901</lpage>.<pub-id pub-id-type="pmid">17192296</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0069">
<label>69</label>
<mixed-citation id="obr12836-cit-0070" publication-type="journal">
<string-name>
<surname>Gunderson</surname>
<given-names>EP</given-names>
</string-name>. <article-title>Childbearing and obesity in women: weight before, during, and after pregnancy</article-title>. <source xml:lang="en"/>Obstet Gynecol Clin North Am. <year>2009</year>;<volume>36</volume>(<issue>2</issue>):<fpage>317</fpage>‐<lpage>332</lpage>. ix<pub-id pub-id-type="pmid">19501316</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0070">
<label>70</label>
<mixed-citation id="obr12836-cit-0071" publication-type="journal">
<string-name>
<surname>Davis</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Castelo‐Branco</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chedraui</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Understanding weight gain at menopause</article-title>. <source xml:lang="en"/>Climacteric. <year>2012</year>;<volume>15</volume>(<issue>5</issue>):<fpage>419</fpage>‐<lpage>429</lpage>.<pub-id pub-id-type="pmid">22978257</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0071">
<label>71</label>
<mixed-citation id="obr12836-cit-0072" publication-type="journal">
<string-name>
<surname>Molitch</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Clemmons</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Malozowski</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Merriam</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Vance</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Endocrine</surname>
<given-names>S</given-names>
</string-name>. <article-title>Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metab. <year>2011</year>;<volume>96</volume>(<issue>6</issue>):<fpage>1587</fpage>‐<lpage>1609</lpage>.<pub-id pub-id-type="pmid">21602453</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0072">
<label>72</label>
<mixed-citation id="obr12836-cit-0073" publication-type="journal">
<string-name>
<surname>Maison</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Griffin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nicoue‐Beglah</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH‐deficient adults: a metaanalysis of blinded, randomized, placebo‐controlled trials</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metab. <year>2004</year>;<volume>89</volume>(<issue>5</issue>):<fpage>2192</fpage>‐<lpage>2199</lpage>.<pub-id pub-id-type="pmid">15126541</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0073">
<label>73</label>
<mixed-citation id="obr12836-cit-0074" publication-type="journal">
<string-name>
<surname>Cenci</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Conceicao</surname>
<given-names>FL</given-names>
</string-name>, <string-name>
<surname>Soares</surname>
<given-names>DV</given-names>
</string-name>, et al. <article-title>Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone‐deficient adults</article-title>. <source xml:lang="en"/>Metabolism. <year>2008</year>;<volume>57</volume>(<issue>1</issue>):<fpage>121</fpage>‐<lpage>129</lpage>.<pub-id pub-id-type="pmid">18078869</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0074">
<label>74</label>
<mixed-citation id="obr12836-cit-0075" publication-type="journal">
<string-name>
<surname>Bereket</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kiess</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lustig</surname>
<given-names>RH</given-names>
</string-name>, et al. <article-title>Hypothalamic obesity in children</article-title>. <source xml:lang="en"/>Obes Rev. <year>2012</year>;<volume>13</volume>(<issue>9</issue>):<fpage>780</fpage>‐<lpage>798</lpage>.<pub-id pub-id-type="pmid">22577758</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0075">
<label>75</label>
<mixed-citation id="obr12836-cit-0076" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Korner</surname>
<given-names>J</given-names>
</string-name>. <article-title>Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans</article-title>. <source xml:lang="en"/>Pituitary. <year>2009</year>;<volume>12</volume>(<issue>2</issue>):<fpage>87</fpage>‐<lpage>95</lpage>.<pub-id pub-id-type="pmid">18327643</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0076">
<label>76</label>
<mixed-citation id="obr12836-cit-0077" publication-type="journal">
<string-name>
<surname>Faith</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Butryn</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wadden</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Fabricatore</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Heymsfield</surname>
<given-names>SB</given-names>
</string-name>. <article-title>Evidence for prospective associations among depression and obesity in population‐based studies</article-title>. <source xml:lang="en"/>Obes Rev. <year>2011</year>;<volume>12</volume>(<issue>5</issue>):<fpage>e438</fpage>‐<lpage>e453</lpage>.<pub-id pub-id-type="pmid">21414128</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0077">
<label>77</label>
<mixed-citation id="obr12836-cit-0078" publication-type="journal">
<string-name>
<surname>de Wit</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Luppino</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>van Straten</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Penninx</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zitman</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Cuijpers</surname>
<given-names>P</given-names>
</string-name>. <article-title>Depression and obesity: a meta‐analysis of community‐based studies</article-title>. <source xml:lang="en"/>Psychiatry Res. <year>2010</year>;<volume>178</volume>(<issue>2</issue>):<fpage>230</fpage>‐<lpage>235</lpage>.<pub-id pub-id-type="pmid">20462641</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0078">
<label>78</label>
<mixed-citation id="obr12836-cit-0080" publication-type="journal">
<string-name>
<surname>Milaneschi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Simmons</surname>
<given-names>WK</given-names>
</string-name>, <string-name>
<surname>van Rossum</surname>
<given-names>EFC</given-names>
</string-name>, <string-name>
<surname>Penninx</surname>
<given-names>BW</given-names>
</string-name>. <article-title>Depression and obesity: evidence of shared biological mechanisms</article-title>. <source xml:lang="en"/>Mol Psychiatry. <year>2018</year>;<volume>24</volume>:<fpage>18</fpage>‐<lpage>38</lpage>.<pub-id pub-id-type="pmid">29453413</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0079">
<label>79</label>
<mixed-citation id="obr12836-cit-0079" publication-type="book">
<collab collab-type="authors">Association AP</collab>
. <source xml:lang="en"/>Diagnostic and Statistical Manual of Mental Disorders. <edition>5th</edition> ed. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>; <year>2013</year>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0080">
<label>80</label>
<mixed-citation id="obr12836-cit-0081" publication-type="journal">
<string-name>
<surname>Rajan</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Menon</surname>
<given-names>V</given-names>
</string-name>. <article-title>Psychiatric disorders and obesity: a review of association studies</article-title>. <source xml:lang="en"/>J Postgrad Med. <year>2017</year>;<volume>63</volume>(<issue>3</issue>):<fpage>182</fpage>‐<lpage>190</lpage>.<pub-id pub-id-type="pmid">28695871</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0081">
<label>81</label>
<mixed-citation id="obr12836-cit-0082" publication-type="journal">
<string-name>
<surname>Hudson</surname>
<given-names>JI</given-names>
</string-name>, <string-name>
<surname>Hiripi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Pope</surname>
<given-names>HG</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Kessler</surname>
<given-names>RC</given-names>
</string-name>. <article-title>The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication</article-title>. <source xml:lang="en"/>Biol Psychiatry. <year>2007</year>;<volume>61</volume>(<issue>3</issue>):<fpage>348</fpage>‐<lpage>358</lpage>.<pub-id pub-id-type="pmid">16815322</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0082">
<label>82</label>
<mixed-citation id="obr12836-cit-0083" publication-type="journal">
<string-name>
<surname>Dallman</surname>
<given-names>MF</given-names>
</string-name>. <article-title>Stress‐induced obesity and the emotional nervous system</article-title>. <source xml:lang="en"/>Trends Endocrinol Metab. <year>2010</year>;<volume>21</volume>(<issue>3</issue>):<fpage>159</fpage>‐<lpage>165</lpage>.<pub-id pub-id-type="pmid">19926299</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0083">
<label>83</label>
<mixed-citation id="obr12836-cit-0084" publication-type="journal">
<string-name>
<surname>Tamashiro</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Sakai</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Shively</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Karatsoreos</surname>
<given-names>IN</given-names>
</string-name>, <string-name>
<surname>Reagan</surname>
<given-names>LP</given-names>
</string-name>. <article-title>Chronic stress, metabolism, and metabolic syndrome</article-title>. <source xml:lang="en"/>Stress. <year>2011</year>;<volume>14</volume>(<issue>5</issue>):<fpage>468</fpage>‐<lpage>474</lpage>.<pub-id pub-id-type="pmid">21848434</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0084">
<label>84</label>
<mixed-citation id="obr12836-cit-0085" publication-type="journal">
<string-name>
<surname>Kiecolt‐Glaser</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Fagundes</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Andridge</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Depression, daily stressors and inflammatory responses to high‐fat meals: when stress overrides healthier food choices</article-title>. <source xml:lang="en"/>Mol Psychiatry. <year>2017</year>;<volume>22</volume>(<issue>3</issue>):<fpage>476</fpage>‐<lpage>482</lpage>.<pub-id pub-id-type="pmid">27646264</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0085">
<label>85</label>
<mixed-citation id="obr12836-cit-0086" publication-type="journal">
<string-name>
<surname>Tomiyama</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Weight stigma is stressful. A review of evidence for the cyclic obesity/weight‐based stigma model</article-title>. <source xml:lang="en"/>Appetite. <year>2014</year>;<volume>82</volume>:<fpage>8</fpage>‐<lpage>15</lpage>.<pub-id pub-id-type="pmid">24997407</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0086">
<label>86</label>
<mixed-citation id="obr12836-cit-0087" publication-type="journal">
<string-name>
<surname>Fuemmeler</surname>
<given-names>BF</given-names>
</string-name>, <string-name>
<surname>Dedert</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>McClernon</surname>
<given-names>FJ</given-names>
</string-name>, <string-name>
<surname>Beckham</surname>
<given-names>JC</given-names>
</string-name>. <article-title>Adverse childhood events are associated with obesity and disordered eating: results from a U.S. population‐based survey of young adults</article-title>. <source xml:lang="en"/>J Trauma Stress. <year>2009</year>;<volume>22</volume>(<issue>4</issue>):<fpage>329</fpage>‐<lpage>333</lpage>.<pub-id pub-id-type="pmid">19588510</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0087">
<label>87</label>
<mixed-citation id="obr12836-cit-0088" publication-type="miscellaneous">
<string-name>
<surname>Bergman</surname>
<given-names>Å</given-names>
</string-name>, <string-name>
<surname>Heindel</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Jobling</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kidd</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Zoeller</surname>
<given-names>RT</given-names>
</string-name>, 
<collab collab-type="authors">Programme WHoatUNE</collab>
. <article-title>Endocrine Disrupting Chemicals</article-title>. <year>2012</year>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0088">
<label>88</label>
<mixed-citation id="obr12836-cit-0089" publication-type="journal">
<string-name>
<surname>Darbre</surname>
<given-names>PD</given-names>
</string-name>. <article-title>Endocrine disruptors and obesity</article-title>. <source xml:lang="en"/>Curr Obes Rep. <year>2017</year>;<volume>6</volume>(<issue>1</issue>):<fpage>18</fpage>‐<lpage>27</lpage>.<pub-id pub-id-type="pmid">28205155</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0089">
<label>89</label>
<mixed-citation id="obr12836-cit-0090" publication-type="journal">
<string-name>
<surname>Qiao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Birth weight and childhood obesity: a 12‐country study</article-title>. <source xml:lang="en"/>Int J Obes Suppl. <year>2015</year>;<volume>5</volume>(<issue>Suppl 2</issue>):<fpage>S74</fpage>‐<lpage>S79</lpage>.<pub-id pub-id-type="pmid">27152189</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0090">
<label>90</label>
<mixed-citation id="obr12836-cit-0091" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ferber</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Odouli</surname>
<given-names>R</given-names>
</string-name>. <article-title>Infection and antibiotic use in infancy and risk of childhood obesity: a longitudinal birth cohort study</article-title>. <source xml:lang="en"/>Lancet Diabetes Endocrinol. <year>2017</year>;<volume>5</volume>(<issue>1</issue>):<fpage>18</fpage>‐<lpage>25</lpage>.<pub-id pub-id-type="pmid">27815091</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0091">
<label>91</label>
<mixed-citation id="obr12836-cit-0092" publication-type="journal">
<string-name>
<surname>Xu</surname>
<given-names>MY</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>DF</given-names>
</string-name>, et al. <article-title>Human adenovirus 36 infection increased the risk of obesity: a meta‐analysis update</article-title>. <source xml:lang="en"/>Medicine (Baltimore). <year>2015</year>;<volume>94</volume>(<issue>51</issue>):<elocation-id>e2357</elocation-id>.<pub-id pub-id-type="pmid">26705235</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0092">
<label>92</label>
<mixed-citation id="obr12836-cit-0093" publication-type="journal">
<string-name>
<surname>Bouter</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>van Raalte</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Groen</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Nieuwdorp</surname>
<given-names>M</given-names>
</string-name>. <article-title>Role of the gut microbiome in the pathogenesis of obesity and obesity‐related metabolic dysfunction</article-title>. <source xml:lang="en"/>Gastroenterology. <year>2017</year>;<volume>152</volume>(<issue>7</issue>):<fpage>1671</fpage>‐<lpage>1678</lpage>.<pub-id pub-id-type="pmid">28192102</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0093">
<label>93</label>
<mixed-citation id="obr12836-cit-0094" publication-type="journal">
<string-name>
<surname>Wu</surname>
<given-names>FC</given-names>
</string-name>, <string-name>
<surname>Tajar</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Beynon</surname>
<given-names>JM</given-names>
</string-name>, et al. <article-title>Identification of late‐onset hypogonadism in middle‐aged and elderly men</article-title>. <source xml:lang="en"/>N Engl J Med. <year>2010</year>;<volume>363</volume>(<issue>2</issue>):<fpage>123</fpage>‐<lpage>135</lpage>.<pub-id pub-id-type="pmid">20554979</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0094">
<label>94</label>
<mixed-citation id="obr12836-cit-0095" publication-type="journal">
<string-name>
<surname>Gafoor</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Booth</surname>
<given-names>HP</given-names>
</string-name>, <string-name>
<surname>Gulliford</surname>
<given-names>MC</given-names>
</string-name>. <article-title>Antidepressant utilisation and incidence of weight gain during 10 years' follow‐up: population based cohort study</article-title>. <source xml:lang="en"/>BMJ. <year>2018</year>;<volume>361</volume>:<fpage>k1951</fpage>.<pub-id pub-id-type="pmid">29793997</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0095">
<label>95</label>
<mixed-citation id="obr12836-cit-0096" publication-type="journal">
<string-name>
<surname>Maayan</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Correll</surname>
<given-names>CU</given-names>
</string-name>. <article-title>Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents</article-title>. <source xml:lang="en"/>J Child Adolesc Psychopharmacol. <year>2011</year>;<volume>21</volume>(<issue>6</issue>):<fpage>517</fpage>‐<lpage>535</lpage>.<pub-id pub-id-type="pmid">22166172</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0096">
<label>96</label>
<mixed-citation id="obr12836-cit-0097" publication-type="journal">
<string-name>
<surname>Medici</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>McClave</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>KR</given-names>
</string-name>. <article-title>Common medications which Lead to unintended alterations in weight gain or organ Lipotoxicity</article-title>. <source xml:lang="en"/>Curr Gastroenterol Rep. <year>2016</year>;<volume>18</volume>(<issue>1</issue>):<fpage>2</fpage>.<pub-id pub-id-type="pmid">26700070</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0097">
<label>97</label>
<mixed-citation id="obr12836-cit-0098" publication-type="journal">
<string-name>
<surname>Lampl</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Eshel</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Rapaport</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sarova‐Pinhas</surname>
<given-names>I</given-names>
</string-name>. <article-title>Weight gain, increased appetite, and excessive food intake induced by carbamazepine</article-title>. <source xml:lang="en"/>Clin Neuropharmacol. <year>1991</year>;<volume>14</volume>(<issue>3</issue>):<fpage>251</fpage>‐<lpage>255</lpage>.<pub-id pub-id-type="pmid">2070366</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0098">
<label>98</label>
<mixed-citation id="obr12836-cit-0099" publication-type="journal">
<string-name>
<surname>Hodish</surname>
<given-names>I</given-names>
</string-name>. <article-title>Insulin therapy, weight gain and prognosis</article-title>. <source xml:lang="en"/>Diabetes Obes Metab. <year>2018</year>;<volume>20</volume>(<issue>9</issue>):<fpage>2085</fpage>‐<lpage>2092</lpage>.<pub-id pub-id-type="pmid">29785843</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0099">
<label>99</label>
<mixed-citation id="obr12836-cit-0100" publication-type="journal">
<string-name>
<surname>Hemmingsen</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Schroll</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Wetterslev</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta‐analysis of randomized clinical trials and trial sequential analysis</article-title>. <source xml:lang="en"/>CMAJ Open. <year>2014</year>;<volume>2</volume>(<issue>3</issue>):<fpage>E162</fpage>‐<lpage>E175</lpage>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0100">
<label>100</label>
<mixed-citation id="obr12836-cit-0101" publication-type="journal">
<string-name>
<surname>Bryson</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Psaty</surname>
<given-names>BM</given-names>
</string-name>. <article-title>A review of the adverse effects of peripheral Alpha‐1 antagonists in hypertension therapy</article-title>. <source xml:lang="en"/>Curr Control Trials Cardiovasc Med. <year>2002</year>;<volume>3</volume>(<issue>1</issue>):<fpage>7</fpage>.<pub-id pub-id-type="pmid">12097149</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0101">
<label>101</label>
<mixed-citation id="obr12836-cit-0102" publication-type="journal">
<string-name>
<surname>Curtis</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Westfall</surname>
<given-names>AO</given-names>
</string-name>, <string-name>
<surname>Allison</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Population‐based assessment of adverse events associated with long‐term glucocorticoid use</article-title>. <source xml:lang="en"/>Arthritis Rheum. <year>2006</year>;<volume>55</volume>(<issue>3</issue>):<fpage>420</fpage>‐<lpage>426</lpage>.<pub-id pub-id-type="pmid">16739208</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0102">
<label>102</label>
<mixed-citation id="obr12836-cit-0103" publication-type="journal">
<string-name>
<surname>Czwornog</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Austin</surname>
<given-names>GL</given-names>
</string-name>. <article-title>Association of Proton Pump Inhibitor (PPI) use with energy intake, physical activity, and weight gain</article-title>. <source xml:lang="en"/>Nutrients. <year>2015</year>;<volume>7</volume>(<issue>10</issue>):<fpage>8592</fpage>‐<lpage>8601</lpage>.<pub-id pub-id-type="pmid">26492268</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0103">
<label>103</label>
<mixed-citation id="obr12836-cit-0104" publication-type="journal">
<string-name>
<surname>Ward</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Jensen‐Otsu</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Schoen</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Rothchild</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mitchell</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Austin</surname>
<given-names>GL</given-names>
</string-name>. <article-title>Acid suppression medications are associated with suboptimal weight loss after laparoscopic roux‐en‐Y gastric bypass in patients older than 40 years</article-title>. <source xml:lang="en"/>Surg Obes Relat Dis. <year>2015</year>;<volume>11</volume>(<issue>3</issue>):<fpage>585</fpage>‐<lpage>590</lpage>.<pub-id pub-id-type="pmid">25553887</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0104">
<label>104</label>
<mixed-citation id="obr12836-cit-0105" publication-type="journal">
<string-name>
<surname>Anuurad</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bremer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Berglund</surname>
<given-names>L</given-names>
</string-name>. <article-title>HIV protease inhibitors and obesity</article-title>. <source xml:lang="en"/>Curr Opin Endocrinol Diabetes Obes. <year>2010</year>;<volume>17</volume>(<issue>5</issue>):<fpage>478</fpage>‐<lpage>485</lpage>.<pub-id pub-id-type="pmid">20717021</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0105">
<label>105</label>
<mixed-citation id="obr12836-cit-0106" publication-type="journal">
<string-name>
<surname>Willig</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Overton</surname>
<given-names>ET</given-names>
</string-name>. <article-title>Metabolic complications and glucose metabolism in HIV infection: a review of the evidence</article-title>. <source xml:lang="en"/>Curr HIV/AIDS Rep. <year>2016</year>;<volume>13</volume>(<issue>5</issue>):<fpage>289</fpage>‐<lpage>296</lpage>.<pub-id pub-id-type="pmid">27541600</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0106">
<label>106</label>
<mixed-citation id="obr12836-cit-0107" publication-type="journal">
<string-name>
<surname>Huvenne</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Dubern</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Clement</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Poitou</surname>
<given-names>C</given-names>
</string-name>. <article-title>Rare genetic forms of obesity: clinical approach and current treatments in 2016</article-title>. <source xml:lang="en"/>Obes Facts. <year>2016</year>;<volume>9</volume>(<issue>3</issue>):<fpage>158</fpage>‐<lpage>173</lpage>.<pub-id pub-id-type="pmid">27241181</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0107">
<label>107</label>
<mixed-citation id="obr12836-cit-0108" publication-type="journal">
<string-name>
<surname>Cassidy</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Driscoll</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>Prader‐Willi syndrome</article-title>. <source xml:lang="en"/>Eur J Hum Genet. <year>2009</year>;<volume>17</volume>(<issue>1</issue>):<fpage>3</fpage>‐<lpage>13</lpage>.<pub-id pub-id-type="pmid">18781185</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0108">
<label>108</label>
<mixed-citation id="obr12836-cit-0109" publication-type="journal">
<string-name>
<surname>Forsythe</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Beales</surname>
<given-names>PL</given-names>
</string-name>. <article-title>Bardet‐Biedl syndrome</article-title>. <source xml:lang="en"/>Eur J Hum Genet. <year>2013</year>;<volume>21</volume>(<issue>1</issue>):<fpage>8</fpage>‐<lpage>13</lpage>.<pub-id pub-id-type="pmid">22713813</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0109">
<label>109</label>
<mixed-citation id="obr12836-cit-0110" publication-type="journal">
<string-name>
<surname>Dell'Edera</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Dilucca</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Allegretti</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>16p11.2 microdeletion syndrome: a case report</article-title>. <source xml:lang="en"/>J Med Case Reports. <year>2018</year>;<volume>12</volume>(<issue>1</issue>):<fpage>90</fpage>.</mixed-citation>
</ref>
<ref id="obr12836-bib-0110">
<label>110</label>
<mixed-citation id="obr12836-cit-0111" publication-type="journal">
<string-name>
<surname>Martinelli</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Keogh</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Greenfield</surname>
<given-names>JR</given-names>
</string-name>, et al. <article-title>Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion</article-title>. <source xml:lang="en"/>J Clin Endocrinol Metab. <year>2011</year>;<volume>96</volume>(<issue>1</issue>):<fpage>E181</fpage>‐<lpage>E188</lpage>.<pub-id pub-id-type="pmid">21047921</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0111">
<label>111</label>
<mixed-citation id="obr12836-cit-0112" publication-type="journal">
<string-name>
<surname>Vollbach</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Brandt</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lahr</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort</article-title>. <source xml:lang="en"/>Int J Obes (Lond). <year>2017</year>;<volume>41</volume>(<issue>1</issue>):<fpage>13</fpage>‐<lpage>22</lpage>.<pub-id pub-id-type="pmid">27654141</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0112">
<label>112</label>
<mixed-citation id="obr12836-cit-0113" publication-type="journal">
<string-name>
<surname>Farooqi</surname>
<given-names>IS</given-names>
</string-name>, <string-name>
<surname>Wangensteen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Collins</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor</article-title>. <source xml:lang="en"/>N Engl J Med. <year>2007</year>;<volume>356</volume>(<issue>3</issue>):<fpage>237</fpage>‐<lpage>247</lpage>.<pub-id pub-id-type="pmid">17229951</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0113">
<label>113</label>
<mixed-citation id="obr12836-cit-0114" publication-type="journal">
<string-name>
<surname>Krude</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Biebermann</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gruters</surname>
<given-names>A</given-names>
</string-name>. <article-title>Mutations in the human proopiomelanocortin gene review</article-title>. <source xml:lang="en"/>Ann N Y Acad Sci. <year>2003</year>;<volume>994</volume>:<fpage>233</fpage>‐<lpage>239</lpage>.<pub-id pub-id-type="pmid">12851321</pub-id></mixed-citation>
</ref>
<ref id="obr12836-bib-0114">
<label>114</label>
<mixed-citation id="obr12836-cit-0115" publication-type="journal">
<string-name>
<surname>Ramos‐Molina</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Lindberg</surname>
<given-names>I</given-names>
</string-name>. <article-title>PCSK1 variants and human obesity</article-title>. <source xml:lang="en"/>Prog Mol Biol Transl Sci. <year>2016</year>;<volume>140</volume>:<fpage>47</fpage>‐<lpage>74</lpage>.<pub-id pub-id-type="pmid">27288825</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>